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Impact of Seizure-Related Variables and Psychopathology on Health-Related Quality of  
Life in Pediatric Epilepsy 
 
Aja M. Meyer 
ABSTRACT  
Psychopathology typically is a lasting condition that is persistent from childhood 
to adulthood. Therefore, it is imperative that children with health conditions and 
comorbid psychiatric disorders are treated for both conditions as they are likely to have a 
significant negative impact on children’s overall health-related quality of life (HRQL). 
More specifically, it is important to identify the variables that affect HRQL in children 
with epilepsy. Research has shown that biomedical variables such as seizure severity and 
frequency have only moderate relationships with HRQL; therefore, additional factors, 
such as depression and anxiety, must be identified so that they also may be a focus of 
treatment.  
 The purpose of this study was to ascertain the relationship among seizure-related 
variables, health-related quality of life, and psychopathology (i.e., anxiety and 
depression) in children with epilepsy (n = 51). The seizure-related variables examined in 
this study include type of seizure, seizure frequency, and seizure treatment with anti-
epileptic drugs (AEDs). Canonical correlation analyses indicated that self-report and 
parent report of anxiety and depression were most strongly correlated with HRQL. 
Additionally, seizure frequency and number of anti-epileptic drugs also were correlated 
with HRQL. It is hoped that results from this study will inform both the medical and 
 vii
psychosocial treatment children with epilepsy receive. This comprehensive care needs to 
go beyond simply attempting to control seizures with minimal adverse drug reactions. 
Results from this study will contribute to the literature underscoring the importance of 
identifying, diagnosing, and treating children with epilepsy who have comorbid 
psychopathology so that they have the best possible psychosocial outcomes. 
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Chapter 1 
Introduction 
Statement of the Problem 
 A thorough review of the literature reveals that approximately 10% to 15% of 
school-aged children in the United States are inflicted with a chronic medical condition 
(Bethell et al., 2002; Davidoff, 2004; Van Dyck et al., 2002). Of these conditions, 
epilepsy is one of the most physically and psychosocially debilitating chronic illnesses in 
children (Devinsky, 2003). Epilepsy is a neurological condition that affects the central 
nervous system and has various origins, symptoms, courses, and prognoses (Shafer, 
2002). Pediatric epilepsy is one of the most common neurological conditions, with a 
prevalence rate of 3.6 to 5.0 per 1,000 for children, birth to adolescence, in developed 
countries (Hiemenz, Hynd, & Jimenez, 1999; Ronen, Streiner, & Rosenbaum, 2003). 
According to the United States Census Bureau, there were 58 million students, 
kindergarten through 12th grade, enrolled in public schools in 2003. Thus, the above-
cited pediatric epilepsy prevalence rates indicate that approximately 290,000 school-aged 
children in the United States have epilepsy. However, according to Sachs and Barrett 
(1995), as many as 500,000 children and adolescents in the United States may experience 
recurrent seizures. 
Physical health and mental health are intertwined (Huberty, Austin, & Huster, 
2000); therefore, it is important to assess the mental health of individuals who have 
chronic medical conditions such as epilepsy. Given that depression and anxiety have been 
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found to be the most prevalent co-morbid psychiatric disorders in adults with epilepsy 
(Caplan, Siddarth, & Gurbani, 2005), it is crucial for practitioners to ascertain how 
depression and anxiety manifest in children with epilepsy. This is especially important 
given recent research findings with adults that indicate depression, through the 
mechanism of sleep deprivation, can have a direct impact on seizure frequency, 
increasing the rate of seizures and negatively impacting health-related quality of life 
(HRQL) (Jackson & Turkington, 2005).  
 Empirical studies demonstrate a relationship between psychopathology and poor 
quality of life in children (Bastiaansen, Koot, & Ferdinand, 2005). Furthermore, research 
has found that children with physical illness have a poorer HRQL (Baker, Spector, 
McGrath, & Soteriou, 2005). Therefore, the risk for compromised quality of life is 
confounded in children with physical/medical conditions (e.g., epilepsy) and comorbid 
psychopathology (Wagner & Smith, 2006). In light of these research findings, there is a 
need to explore the impact of psychopathology (especially depression and anxiety) on the 
HRQL of children with epilepsy so that appropriate treatment may be provided early for 
optimal health outcomes.  
Pediatric Epilepsy 
 Pediatric epilepsy is a neurological condition wherein abrupt changes in how 
cells in the brain send electrical signals cause seizures in children. Epilepsy is a 
condition of chronic, recurring seizures. A seizure occurs when there is a sudden 
discharge or disturbance of the electrochemical firing of neurons in the brain that may 
cause a change in an individual’s sensation, awareness, and/or behavior (DuLac, 
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MacDonald, & Kelly, 1995). Pediatric epilepsy is a condition that has various origins, 
symptoms, courses, and prognoses for children (Shafer, 2002).  
 Numerous factors contribute to the medical and psychosocial difficulties faced by 
children with epilepsy. For example, the type and frequency of the seizures may be 
correlated with increased difficulties both medically and psychosocially. Frequency of 
seizures has been found to be correlated with behavioral problems in children with 
epilepsy (Austin, Risinger, & Beckett, 1992; Lambert & Robertson, 1999). Furthermore, 
there are some data to support a relationship between seizure frequency and anxiety, 
whereby increased levels of stress and anxiety appear to escalate the frequency of 
seizures (Vazquez & Devinsky, 2003). Finally, the use of antiepileptic drugs (AEDs) may 
produce negative side effects in children with epilepsy. Mendez, Doss, Taylor, and 
Salguero (1993) found that the use of multiple AEDs was associated with depression in 
children with epilepsy. Presently, there is a dearth of research examining the relationship 
between various seizure-related variables and psychopathology, and the data that have 
been collected are inconclusive. Therefore, it is imperative that researchers determine the 
impact of seizure-related variables on psychopathology in children with epilepsy. 
Pediatric Epilepsy and Psychopathology 
Along with the goal of reducing or eliminating seizures, practitioners also must 
focus on the individual’s psychosocial adjustment to promote the most optimal outcomes 
for children with epilepsy. Therefore, it is problematic that treatment of pediatric epilepsy 
has focused primarily on seizure control and treatment adherence while overlooking 
learning and behavior problems as well as comorbid psychopathology. Because 
recognition of the relationship between pediatric epilepsy and comorbid psychopathology 
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is newly emerging in the literature, a comprehensive approach to assessing and treating 
these children has not yet been established (Caplan et al., 2005). Broadband assessment 
instruments provide information on an individual’s functioning in multiple domains; a 
number of empirically-based broadband measures of emotional and behavioral symptoms 
in children may be utilized to assess the presence of psychopathology (e.g., Child 
Behavior Checklist; Achenbach, 2000; Behavior Assessment System for Children; 
Reynolds & Kamphaus, 2004).  
Pediatric Epilepsy and Health-Related Quality of Life 
 Quality of life refers to an individual's ability to engage in and enjoy normal life 
activities (Bastiaansen et al., 2005). More specifically, health-related quality of life 
(HRQL) represents the functional effects of an illness and its subsequent treatment on a 
patient, as perceived by the individual (Baker, 2001). Several groups of researchers 
(Bastiaansen, Koot, Ferdinand, & Verhulst, 2004; Sawyer, Whaites, & Rey, 2002) have 
conducted studies examining quality of life (QoL) in children with psychiatric disorders. 
Their findings revealed that children with psychiatric disorders had poor QoL. Moreover, 
not only were these children’s QoL considerably lower than children from the population 
at large, but their QoL also was poorer than the QoL of physically ill children.  
 These results suggest that there is a relationship between poor QoL and 
psychopathology in children (Bastiaansen et al., 2005). In addition, these findings have 
revealed that not only do children with physical illness have a poorer QoL (as compared 
with healthy children), but children with psychiatric disorders also have lowered QoL. In 
light of these findings, it is reasonable to hypothesize that children with a physical illness 
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such as epilepsy as well as a psychiatric disorder (e.g., anxiety and depression) are at a 
substantially greater risk for a poor QoL. 
Implications for School Psychology 
 Children with chronic health conditions have increased risk factors for poor 
academic and psychosocial functioning compared with their healthy peers (Thompson & 
Gustafson, 1996). A number of researchers (e.g., Aldenkamp, Overweg-Plandsoen, & 
Arends, 1999; Besag, 1995; Lhatoo & Sander, 2001) have found that children with 
epilepsy display significant difficulties in learning and behavior compared to healthy 
children. Furthermore, research has shown that children with chronic neurological 
conditions such as epilepsy are more likely to experience academic difficulties compared 
to those whose illness does not have a neurological basis (Howe, Feinstein, & Reiss, 
1993). Although it has been hypothesized that academic difficulties may be due to limited 
intellectual ability, researchers have found that these differences in academic 
achievement in children with epilepsy are not attributed to limited cognitive functioning 
(Seidenberg & Berent, 1992; Sturniolo & Galletti, 1994). Unfortunately, the origin of 
these difficulties still has not been ascertained. It is hypothesized that learning and 
behavior problems may be due to factors such as seizure-related variables, 
pharmacological treatment (e.g., AEDs), or environmental factors (e.g., social 
interactions) that impact children with epilepsy (Bourgeois, 1998).  
 When children experience learning and behavior problems, it is likely that there 
will be a direct impact on their academic and behavioral performance at school. Because 
chronic health conditions such as epilepsy impact a multitude of domains, educational 
laws have been created to ensure appropriate support for individuals with chronic 
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conditions in the educational system. One such law that pertains to the education of 
children and adolescents with disabilities is the Reauthorization of Individuals with 
Disabilities Education Act (IDEA; United States Department of Education, 2004). Other 
Health Impaired is a category under IDEA that provides services to students with health 
conditions such as epilepsy. The reauthorization of IDEA stipulates that educators, 
including school psychologists, are obligated to provide supports and services to students 
whose chronic health condition negatively impacts their academic and behavioral 
functioning. Furthermore, the Rehabilitation Act of 1973 states that children with 
physical or mental impairments` are eligible to receive reasonable accommodations in 
school settings under the Section 504 Accommodation Plan. School psychologists could 
play a role in the development and implementation of these accommodation plans to 
support the unique needs of students with chronic conditions. An important difference 
between the IDEA statute and the Section 504 statute is the manner in which disabilities 
are defined, with Section 504 having a much broader definition and encompassing a 
greater number of students with disabilities. 
 Bannon and Ross (1998) found that educators typically have an inadequate 
understanding of chronic childhood illnesses such as epilepsy. This is problematic given 
that the initial identification of seizure-related symptoms, such as unusual staring, 
blinking, and head drops, is commonly made in the school setting (Sachs & Barrett, 
1995). Therefore, it is imperative that educators are knowledgeable about the symptoms 
and the treatment of epilepsy, as well as the impact of the condition on a child’s 
academic, behavioral, and psychosocial functioning. Educators should be aware of 
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students’ specific condition, including their pharmacological and psychological 
treatment, and potential positive and negative effects of the treatment.  
 Furthermore, school psychologists, especially those with expertise in pediatric 
health issues, are in a unique position to act as a liaison among families, educators, and 
medical staff. As such, school psychologists are able to advocate for students with 
chronic health conditions to help alleviate psychosocial problems, as well as to improve 
their medical compliance and enhance their integration into the school setting (Sachs & 
Barrett, 1995). This can be accomplished by the school psychologist providing 
psychoeducation about epilepsy to the individual student, classmates and peers, and the 
entire school staff. Additionally, school psychologists can conduct individual or group 
therapy sessions to address a variety of difficulties the student with epilepsy may be 
experiencing. These difficulties may include problem solving deficits, coping deficits, 
social skills deficits, and/or internalizing (e.g., anxiety and depression) and externalizing 
(e.g., aggression, rule breaking) behaviors. 
Summary 
Psychopathology typically is a condition that persists from childhood to adulthood 
(Hofstra, Van der Ende, & Verhulst, 2000). Therefore, it is imperative that children with 
health conditions and comorbid psychiatric disorders are treated for both conditions as 
they are likely to have a significant negative impact on children’s overall HRQL. More 
specifically, it is important to identify the variables that mediate HRQL in children with 
epilepsy given that researchers have found that the presence of psychopathology also 
negatively impacts children’s HRQL (Bastiaansen et al., 2004; Sawyer et al., 2002). 
Research has shown that biomedical variables such as seizure severity and frequency 
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have only moderate relationships with HRQL; therefore, additional factors, such as 
depression and anxiety, must be identified so that they also may be a focus of treatment 
(Wagner & Smith, 2006). The awareness of possible mediating factors, such as seizure-
related variables and psychopathology, may aid practitioners in the early identification of 
children with epilepsy who are at-risk for poor HRQL.  
Purpose of the Study 
 The purpose of this study was to ascertain the relationship among seizure-related 
variables, health-related quality of life, and psychopathology (i.e., anxiety and 
depression) in children with epilepsy. The seizure-related variables that were examined in 
this study include type of seizure, seizure frequency, and seizure treatment with anti-
epileptic drugs (AEDs). Specifically, type of seizure was classified as either generalized 
or partial. Seizure frequency was classified into two groups: 0-5 seizures per year or 6-12 
seizures per year. Treatment with AEDs was classified as either monotherapy (i.e., 
treatment with one AED) or polytherapy (i.e., treatment with more than one AED). It was 
hoped that results from this study would inform both the medical and psychosocial 
treatment children with epilepsy receive. This comprehensive care needs to go beyond 
simply trying to control seizures with minimal adverse drug reactions. Seizure frequency 
and severity is only one important outcome variable. Other factors, such as psychological 
disorders, also affect children with epilepsy along with their families and close social 
networks. This study further contributes to the literature underscoring the importance of 
identifying, diagnosing, and treating children with epilepsy who have comorbid 
psychopathology so that they have the best possible psychosocial outcomes. 
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Research Questions 
The following research questions were addressed in this study:   
 Research Question 1. What seizure-related variables (i.e., type of seizure, seizure 
frequency, and treatment with AEDs) and psychopathology (“at-risk” or “clinically 
significant” range for anxiety and/or depression) best predict health-related quality of life 
as reported by children 8 to 11 years of age diagnosed with epilepsy?  
 Research Question 2. What seizure-related variables (i.e., type of seizure, seizure 
frequency, and treatment with AEDs) and psychopathology (“at-risk” or “clinically 
significant” range for anxiety and/or depression) best predict health-related quality of life 
as reported by parents of children 8 to 11 years of age diagnosed with epilepsy?   
Hypotheses 
 Two research hypotheses were tested in the current study. First, it was 
hypothesized that children with generalized seizures (as compared with partial seizures), 
frequent seizures (i.e., 6-12 per year compared with 0-5 per year), who receive 
polytherapy (i.e., more than one AED compared with monotherapy) and obtain T scores 
of 60 and higher on the depression scale and/or anxiety scale of the BASC (T scores of 60 
to 69 are in the “at-risk” range and T scores above 69 fall in the “clinically significant” 
range) would obtain a HRQL score in the “highly compromised” (i.e., 5-10) range as 
reported via parent report. Second, it was hypothesized that children with generalized 
seizures (as compared with partial seizures), frequent seizures (i.e., 6-12 per year 
compared with 0-5 per year), who receive polytherapy (i.e., more than one AED 
compared with monotherapy) and obtain T scores of 60 and higher on the depression 
scale and/or anxiety scale of the BASC (T scores of 60 to 69 are in the “at-risk” range and 
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T scores above 69 fall in the “clinically significant” range) would obtain a HRQL score in 
the “highly compromised” range (i.e., 5-10) as reported via self-report. 
Significance of the Study 
 This study provides valuable information about the relationship among seizure-
related variables, psychopathology, and health-related quality of life in children with 
epilepsy. These data will allow practitioners, both psychologists and physicians, to assess 
and treat children with epilepsy by addressing the factors that are correlated with poor 
health-related quality of life. In addition, this study sheds light on the relationship 
between health-related quality of life and psychopathology (i.e., depression and anxiety) 
in children with epilepsy. Because the research clearly supports the importance of 
addressing comorbid psychopathology in children with epilepsy, it is critical that these 
children are identified, diagnosed, and treated to enhance their overall development.   
Definition of Terms 
 Antiepileptic Drugs (AEDs).AEDs are a category of drugs that can help control 
the frequency and severity of seizures; they also are known as anticonvulsants (Kaiser, 
2002). 
 “At-risk” range for anxiety. For the purposes of this manuscript, this phrase refers 
to children with epilepsy who fall into the “at-risk” range (T-score between 60-69) for 
anxiety per scores obtained on the child and/or parent version of the Behavioral 
Assessment Scale for Children, Second Edition (BASC-2, Reynolds & Kamphaus, 2004). 
Please note: Scaled scores in the at-risk range on the BASC-2 are between one and two 
standard deviations from the mean and may signify developing problems that should be 
monitored.  
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 “At-risk” range for depression. For the purposes of this manuscript, this phrase 
refers to children with epilepsy who fall into the “at-risk” range (T score between 60-69) 
for depression per scores obtained on the child and/or parent version of the BASC-2 
(Reynolds & Kamphaus, 2004). 
 “Clinically significant” range for anxiety. This phrase refers to children with 
epilepsy who fall into the “clinically significant” range (T score between 70-100) for 
anxiety per scores obtained on the child and/or parent version of the BASC-2 (Reynolds 
& Kamphaus, 2004). Please note: Scaled scores in the clinically significant range on the 
BASC-2 are two standard deviations or more from the mean and indicate a high level of 
maladaptive behavior. 
 “Clinically significant” range for depression. This phrase refers to children with 
epilepsy who fall into the “clinically significant” range (T score between 70-100) for 
depression per scores obtained on the child and/or parent version of the BASC-2 
(Reynolds & Kamphaus, 2004). 
 Epilepsy. Epilepsy is a chronic neurological condition with abrupt disturbances 
in the electrochemical firing of neurons in the brain cause seizures. This condition of 
unprovoked, recurring seizures affects the central nervous system causing change in an 
individual’s sensation, awareness, and/or behavior and has various origins, symptoms, 
courses, and prognoses (DuLac et al., 1995; Shafer, 2002).  
 Monotherapy. The term monotherapy refers to the use of one antiepileptic drug 
(Labiner & Ahern, 2002). 
 Polytherapy. The term polytherapy refers to the use of more than one type of 
antiepileptic drug (Labiner & Ahern, 2002). 
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 Psychopathology. Psychopathology refers to the study of the manifestation of 
behaviors and experiences that may be indicative of mental illness or psychological 
impairment (Caplan et al., 2005). 
 Seizure. A seizure is an individual episode in which an abrupt discharge of 
electrical activity in the brain may cause changes in sensation, behavior, and/or 
consciousness (DuLac et al., 1995; Ho-Turner & Bennett, 1999). 
 Health-Related Quality of Life (HRQL). Health-related quality of life represents 
the functional effects of an illness and its resulting therapy on a patient, as perceived by 
the individual patient (Baker, 2001). 
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Chapter 2 
Review of the Related Literature 
Overview 
 This chapter provides a review of the literature relevant to this study. Pediatric 
epilepsy is discussed, including its relevance to school psychology, and the importance of 
working within an interdisciplinary framework so that the “whole child” is treated and 
the medical, educational, and psychosocial impact of the disease are addressed. 
Furthermore, prevalence rates, classification, types of seizures, diagnosis, and potential 
causes of epilepsy in children are presented. Pharmacological treatment of pediatric 
epilepsy also is covered, including use of antiepileptic drugs. Next, seizure-related 
variables that may negatively impact children with epilepsy are discussed. The 
relationship between pediatric epilepsy and psychopathology (specifically depression and 
anxiety) and the importance of assessing and treating psychopathology in conjunction 
with medical/seizure treatment also is delineated. Health-related quality of life (HRQL) is 
reviewed, including various epilepsy-specific HRQL measures. The chapter ends with a 
discussion of the importance of assessing both the presence of psychopathology and 
HRQL when developing and implementing treatment plans for children with epilepsy. 
Defining Epilepsy 
 Epilepsy is a neurological condition that affects the nervous system; it is a 
condition of recurrent seizures. It is important to differentiate “seizures” from “epilepsy” 
from the onset of this review. In contrast to epilepsy, a seizure is an individual episode in 
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which an abrupt discharge of electrical activity in the brain may cause changes in 
sensation, behavior, and/or consciousness (DuLac et al., 1995; Ho-Turner & Bennett, 
1999). Seizure disorders (i.e., epilepsy) are chronic, recurring disturbances in the 
electrochemical firing of the neurons in the brain (Ho-Turner & Bennett, 1999). Epilepsy 
is a cluster of disorders that have various origins, symptoms, courses, and prognoses 
(Shafer, 2002). Seizure disorder and epilepsy are synonymous terms that may be used 
interchangeably in this document.  
Prevalence of Epilepsy in Children 
 Epilepsy occurs in approximately 5 out of 1,000 children and is considered to be 
the most prevalent neurological disorder of childhood (Black & Hynd, 1995; Hiemenz et 
al., 1999; Ronen et al., 2003). Although some seizure disorders self-limit as children 
mature, it is reported that more than 80% of adults with epilepsy had their first seizure 
during childhood (Ho-Turner & Bennett, 1999). Incidence and prevalence data are useful 
in developing hypotheses about the cause of an illness. Furthermore, this information aids 
in assessing the health care requirements in a population and in determining diagnostic 
probabilities (Cowan, 2002). When studying epilepsy, however, it is difficult to compare 
incidence and prevalence rates among various populations because of the lack of 
homogeneous methods for defining epilepsy (Ho-Turner & Bennett, 1999).  
 The incidence of epilepsy in children has been estimated from diverse populations 
using different methods of case definition. For example, when examining recurrent, 
unprovoked seizures, the annual incidence rates per 100,000 children ranged from a low 
of 41.0 in Nova Scotia (Camfield, C., Camfield, P., Gordon, Wirrell, & Dooley, 1996) to 
82.3 in Northern Sweden (Blom, Heijbel, & Bergfors, 1978). Cowan (2002) reported that 
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the annual incidence rates across populations are quite similar (i.e., approximately 50-72 
per 100,000), particularly when considering the vast differences in methods of obtaining 
case studies.  
 Despite the vast differences in both methodology and populations used in 
determining prevalence rates of childhood epilepsy, the majority of estimates are 
approximately 4 to 5 per 1,000 children (Eriksson & Koivikko, 1997; Kurtz & Tookey, 
1998). Kurtz et al. (1998) found that prevalence rates ranged from 2 to 3 per 1,000 in 
children up to 7 years of age. However, these researchers found that prevalence rates tend 
to increase with age, with a rate of approximately 4 to 6 per 1,000 in children 11 to 15 
years of age (Kurtz & Tookey, 1998). Furthermore, rates appear to be somewhat higher 
in males than in females (Eriksson & Koivikko, 1997). Differences in rates related to 
ethnicity also have been reported in the literature. Murphy, Yeargin-Allsopp, and 
Decoufle (1995) found slightly higher prevalence rates among African-American 
children compared to Caucasian children. Furthermore, differences in prevalence rates 
have been found in developed versus developing countries. For example, Latin America 
and Africa have been found to have significantly higher prevalence rates (e.g., 10 to 15 
per 1,000) compared to developed countries. The higher rate in developing countries may 
be due to parasitic infections that are common in these countries (Cowan, 2002). 
Classification of Seizures 
 It is difficult to define seizures clinically because there is an infinite variety in the 
clinical manifestations of seizures. However, the international classification scheme is the 
most widely accepted and utilized format for clinical classification of epileptic seizure 
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disorders (Chadwick, 1994). This classification has two major divisions: (a) partial 
seizures, and (b) generalized seizures.   
 Partial seizures occur in one or more restricted regions of the brain. These 
seizures are a secondary effect of a localized physiologic or structural abnormality in the 
brain such as a tumor, dysplasia, or trauma (Prego-Lopez & Devinsky, 2002). Partial 
seizures originate locally in the cortex and are typically preceded by an aura (e.g., visual, 
auditory, or olfactory hallucinations) that reflects the function of the area of the cortex 
where the seizure takes place. These seizures also may be associated with post-ictal focal 
disturbances. Furthermore, partial seizures may spread to become generalized with a 
secondary tonic-clonic seizure (Chadwick, 1994). Partial seizures are further classified as 
either simple, complex, or secondarily generalized. Simple partial seizures alter behavior 
but do not impair consciousness, whereas complex partial seizures alter consciousness by 
impairing awareness, responsiveness, and memory (Prego-Lopez & Devinsky, 2002). 
Secondarily generalized seizures begin as partial seizures (occurring in one area of the 
brain) and then quickly spread throughout both hemispheres, becoming generalized 
seizures. 
 In contrast to partial seizures, generalized seizures occur bilaterally (i.e., in both 
hemispheres of the brain) with consciousness lost suddenly; therefore, the patient does 
not experience an aura (Chadwick, 1994). These seizures are subcategorized into several 
main types, including generalized tonic clonic, myoclonic, absence, and atonic seizures. 
These major types of generalized seizures will be defined briefly. 
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Types of Seizures 
 Generalized tonic-clonic seizures. These seizures also are called Grand Mal 
seizures. These are the most common type of generalized seizure that typically begin with 
a stiffening of the limbs (i.e., tonic phase) followed by a jerking of the limbs and/or face 
(i.e., clonic phase). Breathing may decrease or stop completely during the tonic phase, 
but typically returns (although sometimes irregular) during the clonic phase. The 
presentation of these seizures varies. For example, some individuals may experience only 
the clonic or only the tonic phase. Furthermore, some may experience a tonic-clonic-tonic 
seizure pattern (Ho-Turner & Bennett, 1999). 
 Myoclonic seizures. These seizures present with rapid, brief contractions of 
muscles that typically occur on both sides of the body; however, they may involve only 
one limb. Most of the epileptic syndromes that include myoclonic seizures usually begin 
in childhood. These seizures occur in a variety of epilepsy syndromes that have different 
characteristics such as juvenile myoclonic epilepsy, Lennox-Gastaut syndrome, and 
progressive myoclonic epilepsy. Juvenile myoclonic epilepsy and Lennox-Gastaut 
syndrome will be presented in more detail later in this chapter. 
 Absence seizures. These seizures also are called petit mal seizures. Individuals 
who experience absence seizures may experience lapses of awareness that sometimes 
involve staring episodes that last only a few seconds. Absence seizures are characterized 
by a brief impairment of consciousness, which usually lasts no more than a few seconds. 
The individual simply stares vacantly; neither speaking nor appearing to hear what is 
said. Then, as abruptly as it began, the impairment lifts and the child continues with his 
or her previous activity. Absence seizures are more common in children than in adults; 
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however, they are frequently so short-lived that they avoid detection, even when the child 
is experiencing numerous attacks on a daily basis. Because of the briefness of the 
episodes, it is all too common for children to experience these seizures for several months 
or even years before they are diagnosed (Williams et al., 2002). These seizures most 
frequently develop between 4 and 12 years of age, and very rarely begin after 20 years of 
age.  
 Atonic seizures. These seizures also may be referred to as drop attacks, astatic or 
akinetic seizures. They produce an abrupt loss of muscle tone, which may include the 
head dropping, a loss of posture, or a sudden collapse. Because they occur abruptly, 
individuals who experience atonic seizures typically fall with force. Because this type of 
seizure may result in significant injury to the head and face, protective headgear is 
sometimes used by both children and adults. Unfortunately, these seizures tend to be 
resistant to drug therapy. 
 Electroencephalographic (EEG) results may be used to help differentiate partial 
and generalized seizures. In patients with partial seizures, inter-ictal (i.e., post seizure) 
EEG findings typically show localized spikes, and occasionally associated focal slow 
waves. However, in patients with primarily generalized seizures, EEG findings reveal 
synchronous, high amplitude, generalized spike-wave discharge (Chadwick, 1994).  
Other Classifications of Seizure 
 Classification by cause of seizure. Causes of epileptic seizures are generally 
categorized as either genetic, idiopathic (unknown), or cryptogenic (poorly defined).  
The cause of idiopathic seizures is completely unknown with no evidence of an 
underlying abnormality. An individual with epilepsy is biologically typical, with the 
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exception of the occurrence of seizures. Idiopathic seizures are believed to be inherited 
and are defined by age-related onsets. The cause of cryptogenic seizures is undetermined; 
however, the cause appears to be related to another neurological or cognitive condition 
(Ho-Turner & Bennett, 1999). In addition, seizures may be either developmental or 
acquired, as is the case with symptomatic seizures. Symptomatic seizures also are called 
reactive or provoked seizures--when in response to an irritation (e.g., fever or trauma to 
the brain). They have a known cause that may originate from such ailments as trauma, 
developmental aberrations, metabolic imbalances, or fever (Ho-Turner & Bennett, 1999). 
Therefore, the cause of this type of seizure may be either developmental or acquired. The 
various potential causes of epileptic syndromes will be detailed further in a later section 
of this chapter. 
Common Types of Seizures in Children 
 There are several different types of generalized and partial seizures that are 
common in childhood. Each of these will be reviewed briefly in this section. The 
prevalence rates and common symptoms of the various types of seizures will be 
presented.  
 Neonatal seizures. Neonatal seizures occur from birth up to approximately one 
month of age. The occurrence of these seizures is higher in infants with a familial history 
of epilepsy. Of the infants who experience benign neonatal seizures that are inherited, 
approximately 14% will develop another childhood epilepsy syndrome (Ho-Turner & 
Bennett, 1999). However, the majority of infants experience a spontaneous resolution of 
seizures after two months (Ho-Turner & Bennett, 1999). 
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 Febrile seizures. Febrile seizures are nonepileptic; however, in some cases 
epilepsy may develop. These seizures occur in approximately 4% of children between 6 
months and 5 years of age. These are the most common type of seizures in infancy and 
are caused by high fever (typically over 102.2 degrees Fahrenheit) (Duchowny & Harvey, 
1996). One-half of febrile seizures occur between 12 and 24 months of age, with a peak 
in occurrence between 18 and 24 months of age. The most important predictor of 
recurrence of these seizures is age at occurrence of first seizure (Duchowny, 1993). An 
infant who experiences the first febrile seizure at less than one year of age has 
approximately a 50% chance of recurrence, with the risk of recurrence decreasing as the 
child matures (Hulihan, 1997).  
 Epilepsy has been reported to develop in approximately 1% to 10% of children 
who have a history of febrile seizures (Duchowny, 1993). Epilepsy is most likely to 
develop in children who have experienced complex febrile seizures. Duchowny (1993) 
reported that epilepsy develops in 6% of children with two or more features of complex 
febrile seizures; however, only 0.9% of children with none of these features develop 
epilepsy. 
 Childhood absence epilepsy. This syndrome most often develops between 4 and 8 
years of age. Children with this type of epilepsy are typically neurologically normal, and 
therefore, they are less likely to experience generalized tonic-clonic seizures compared to 
those who experience other types of absence-seizure disorders (Duchowny, 1993). 
Currently, there is no consensus regarding the prognosis for individuals with childhood 
absence epilepsy. However, it is promising that these seizures generally respond 
favorably to anticonvulsant medications in approximately 80% to 95% of children. 
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Furthermore, childhood absence seizures typically abate by mid-adolescence (Duchowny, 
1993). It is still unclear whether this type of seizure has a genetic component; however, 
there typically is a family history of seizures in patients who experience childhood 
absence epilepsy (Duchowny, 1993). 
 Juvenile myoclonic epilepsy. This type of epilepsy is characterized by brief, rapid 
jerks of the shoulders and arms. Many patients also have generalized tonic-clonic 
seizures, and many also suffer absence seizures. Age at onset is typically between 10 and 
17 years. Myoclonic seizures may be precipitated by sleep deprivation or alcohol use. 
 Benign rolandic epilepsy (benign childhood epilepsy with centrotemporal spikes). 
This type of epilepsy is characterized by focal seizures with sensorimotor symptoms most 
commonly affecting the face and oropharynx, although at times with secondary 
generalization to a tonic-clonic seizure. Being the most common epilepsy of childhood, it 
occurs in children who are otherwise neurologically normal. Seizures may be 
predominantly or exclusively nocturnal. The characteristic EEG pattern of this disorder 
can assist in diagnosis in a child who presents with a focal seizure. The same EEG pattern 
has been found in many first-degree relatives of patients with this disorder, indicating a 
strong hereditary component (Zupanc, 1996). Virtually all cases of benign rolandic 
epilepsy remit by mid-adolescence. 
 Benign occipital epilepsy. Also known as epilepsy with occipital paroxysms, this 
is a less common type of idiopathic focal epilepsy. These seizures originate in the 
occipital lobe of the brain and have the potential to generalize to a tonic-clonic seizure. 
Because approximately 47% of children have a family history of seizure, it is believed 
that there is a genetic component for these seizures (Duchowny, 1993). 
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 Infantile spasms. Infantile spasm (IS) is a type of seizure observed in an epilepsy 
syndrome of infancy and early childhood also known as West Syndrome. This syndrome 
is typically detected early in life (i.e., between 3-6 months of age). Infants with IS 
commonly present with a sudden bending forward and stiffening of the body, arms, and 
legs. The spasms tend to occur soon after waking and each spasm typically lasts for 1 to 5 
seconds. These spasms occur in clusters, and range from 2 to as many as 100 spasms at a 
time. Infantile spasms usually remit by 5 years of age, but these spasms are frequently 
replaced with other types of seizure. Along with the infantile spasms, individuals with 
West Syndrome also experience hypsarrhythmia (chaotic brain wave patterns) and mental 
retardation. A close relationship has been detected between IS and Lennox-Gastaut 
Syndrome, which is an epileptic disorder of later childhood. 
 Lennox-Gastaut syndrome. This syndrome is a severe condition characterized by 
mental retardation, multiple seizure types that respond poorly to medication, and often a 
characteristic EEG pattern with slow spike-and-wave discharges. Many patients are 
treated with three or more drugs in combination, which may result in medication toxicity. 
The simplification of anticonvulsant regimens, with reduction in the number of drugs 
used and the discontinuation of barbiturates, may reduce frequency of seizures and 
ameliorate behavioral disturbances.  
Potential Causes of Childhood Epilepsy 
 Cowan (2002) reported that approximately 55% to 75% of all epilepsy cases are 
of unknown cause (i.e., idiopathic), with only 25% to 45% being attributed to specific 
risk factors. There are a number of factors that appear to contribute to seizure threshold 
(an individual’s propensity to experience a seizure) in childhood epilepsy. Ho-Turner and 
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Bennett (1999) identified three main factors that affect seizure occurrence: (a) genetic 
predisposition, (b) seizure threshold, and (c) environmental stressors.  
 It has long been established that certain types of childhood epilepsy have a 
genetic or hereditary component (Ho-Turner & Bennett, 1999). A family history of 
epilepsy appears to increase the risk of developing epilepsy by two to three times 
(Hauser, Annegers, & Rocca, 1996). The reason is unclear, but the risk of developing 
epilepsy is greater in the children of mothers with a history of epilepsy than in children of 
fathers with epilepsy (Annegers et al.). More evidence for a genetic link to the 
development of epilepsy was found in a study conducted by Kjeldsen, Kyvik, 
Christensen, & Friis, (2001). The researchers studied 11,900 pairs of Danish twins to 
ascertain the genetic and environmental factors to the etiology of epilepsy. A 
concordance rate of .37 for monozygotic twins and .08 for dizygotic twins was found for 
epilepsy. In summary, the researchers’ analyses of the data suggested that approximately 
70% to 88% of the proclivity for developing epilepsy may be explained by genetic factors 
(Cowan, 2002).  
 Age alone has a significant influence on an individual’s susceptibility to 
developing epilepsy. Newborns typically have a high cortical threshold; therefore, 
production of a seizure response is quite difficult (Ho-Turner & Bennett, 1999). 
However, as children mature (e.g., around 2 years of age), they develop a greater 
susceptibility to certain types of seizures. Therefore, the majority of childhood epilepsy 
syndromes are first observed around this chronological age. Seizure threshold continues 
to increase proportionally throughout childhood and adolescence until adult levels are 
reached (Ho-Turner & Bennett, 1999). Because an infant’s brain is continually 
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developing through adulthood, to understand childhood epilepsy it is important to study 
the developing brain at various stages. Moreover, there are different implications and 
manifestations of epilepsy depending on the stage of cortical development (i.e., the age of 
the child), as well as differences in prognosis and treatment (Ho-Turner & Bennett, 
1999).  
 Environmental stressors that may trigger a seizure episode include such factors as 
high fever, extreme fatigue or excitement, and metabolism rates (Ho-Turner & Bennett, 
1999). Furthermore, metabolic disorders, hypoxia (i.e., insufficient blood oxygen), 
infectious diseases, and high fevers have been known to produce reactive seizures. 
Additionally, chemical imbalances, drug or poison ingestion, congenital abnormalities 
(e.g., aneurysms), or traumatic brain injuries may lead to seizure (Cowan, 2002; DuLac et 
al., 1995; Heller, Alberto, & Forney, 1996). Overall, in children who survive central 
nervous system infections, the risk of experiencing subsequent unprovoked seizures is 
increased substantially (approximately three-fold). Approximately 50% of childhood 
epilepsy cases go into remission and do not require long-term treatment, whereas around 
25% are intractable and have a less predictable outcome (DuLac et al., 1995). 
Diagnosis of Epilepsy in Children 
 Because of the variety of factors involved, it can be difficult to obtain an accurate 
diagnosis of epilepsy. The child’s medical history must be obtained to help determine the 
cause of the episode. For example, a history of meningitis, encephalitis, head trauma, 
cancer, or cerebrovascular disease could indicate the origin of the seizure. A review of 
the child's medications also should be completed because some medications are 
commonly implicated in seizure. For instance, some antipsychotic drugs (especially 
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clozapine and phenothiazines), radiocontrast dyes, alkylating agents, and ß-lactam 
antibiotics are commonly implicated (Prego-Lopez & Devinsky, 2002). Furthermore, 
general anesthetics, tricyclic antidepressants, newer antidepressants (e.g., selective 
serotonin reuptake inhibitors [SSRIs], bupropion hydrochloride [Wellbutrin]), ß-blockers, 
and decongestants also can cause seizure. Conversely, a child’s medical history may 
indicate a condition other than seizure. A history of other neurological disorders in the 
child or child’s family members may aid in differential diagnosis (Prego-Lopez & 
Devinsky, 2002). 
Treatment of Pediatric Epilepsy 
Initiating Treatment  
 Once an individual is diagnosed with epilepsy, a decision must be made regarding 
treatment. An initial factor in developing a treatment plan is the child's estimated risk of 
seizure recurrence. Hart and Easton (1986) reported that patients with epilepsy are apt to 
experience a second seizure within six months after the first episode. A number of 
researchers have studied the risk of recurrence after the initial seizure. A 5-year 
recurrence risk of 34% was found by Hauser, Rich, and Annegers (1990), whereas 
Hopkins, Garman, and Clark (1988) found a 3-year recurrence risk of 52%. The strongest 
predictors of seizure recurrence are the initial cause of seizure, focal abnormalities, and 
epileptiform abnormalities found on the EEG (Prego-Lopez & Devinsky, 2002). Seizure 
recurrence also may be related to type of seizure. For example, after experiencing the first 
tonic-clonic seizure, depending on additional risk factors, the recurrence rates fluctuate 
from 15% to 60%. After two tonic-clonic seizures, the risk of experiencing another 
seizure increases to approximately 85% (Hauser, 1986). Acute symptomatic seizures, 
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which occur immediately after brain insult, have an increased risk of recurrent seizure 
(Prego-Lopez & Devinsky, 2002). In addition, family history of seizure disorders, 
abnormal patterns on an EEG, or a history of neurologic insult increases the risk of 
recurrence after the first seizure (Hauser, Anderson, & Loewenson, 1982).  
Treatment with Medication 
 A study conducted by the First Seizure Trial Group (1993) investigated 397 
patients with seizure disorder. The researchers found that the risk of seizure recurrence in 
untreated patients was 2.8 times higher than in patients treated with antiepileptic drugs 
(AEDs). The initial selection of medication to treat seizures is based on a number of 
factors that include seizure type, EEG results, concomitant medications, and past medical 
history (Hulihan, 1997).  
 When prescribing AEDs, it is important to be cognizant of the many side effects 
that may accompany the AEDs. Some children may experience feelings of sedation, 
psychomotor slowing, and/or gastrointestinal upset (Prego-Lopez & Devinsky, 2002). In 
rare cases, AEDs can cause severe side effects such as liver failure, bone marrow failure, 
and/or pancreatitis (Prego-Lopez & Devinsky, 2002). Furthermore, some AEDs are 
known to be more likely to induce seizures in patients than other AEDs; therefore, it is 
imperative that medications are carefully selected for each individual depending on the 
patient’s own unique set of factors. Additionally, several medications have been known 
to initiate and/or exacerbate seizure episodes. Psychotropic drugs, such as certain 
antidepressants and major tranquilizers are most commonly indicated, and a majority of 
tricyclic and nontricyclic antidepressant drugs have been linked with an increase in 
seizures as well (Hulihan, 1997).  
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Use of AEDs: Monotherapy versus Polytherapy 
 For each individual child, it is important to weigh the benefits and risks of 
pharmacological treatment. The Collaborative Group for Epidemiology of Epilepsy 
(1986) found that approximately 33% of patients who receive long-term antiepileptic 
treatment experience adverse reactions. Monotherapy (i.e., use of one antiepileptic drug) 
is thought to be tolerated better than polytherapy (i.e., use of multiple antiepileptic 
drugs). However, monotherapy has been reported to cause problems in 20% of patients 
(Labiner & Ahern, 2002). Very young children appear to have increased susceptibility to 
adverse medication effects (Ronen et al., 2003), as well as children with other medical 
problems and those taking concomitant medications. These adverse symptoms often lead 
to treatment failure; therefore, children should be monitored for compliance and adverse 
reactions to pharmacotherapy.  
 Evidence suggests that early identification and diagnosis (soon after the onset of 
the initial seizure) improves outcomes for these at-risk children (Ronen et al., 2003). 
Early diagnosis and pharmacotherapy may indeed reduce seizure recurrence as well as 
decrease the number of antiepileptic drugs needed (i.e., monotherapy rather than 
polytherapy). Additionally, early diagnosis and treatment is likely to minimize the impact 
of epilepsy on a child's overall health-related quality of life. 
Psychopathology and Epilepsy 
 It has been well documented in the literature that children with epilepsy are at-risk 
for psychopathology (McDermott, Mani, & Krishnaswami, 1995; Rodenburg, Stams, 
Meijer, Aldenkamp, & Dekovic, 2005). A prevalence rate ranging from 21% to 60% for 
psychopathology in children with epilepsy has been reported--a three to six times higher 
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risk than that of the general population (Caplan et al., 2004; Devinsky, 2003). An 
epidemiological study conducted by McDermott, Mani, & Krishnaswami (1995) found 
that children with epilepsy are at a 4.7 times greater risk for psychopathology compared 
to children from the general population. This prevalence rate is substantially higher than 
rates in children with other chronic illnesses (Wagner & Smith, 2006). 
Potential Causes of Psychopathology in Pediatric Epilepsy 
 Relationship between seizure type and psychopathology. There are many factors 
that contribute to psychosocial difficulties in children with epilepsy, such as features of 
the actual seizures. The type, location, and frequency of the seizures may have a strong 
correlation with psychosocial problems. For example, if the seizures are located in the 
temporal lobes or limbic structures, they may directly affect emotions and coping, 
because these are crucial areas in the brain that control these emotions. Furthermore, if 
seizures are located in cortical areas, an individual’s cognitive and/or physical 
functioning may be adversely affected. Therefore, it is critical to diagnose and locate the 
focus and type of seizure because seizures significantly impact the child, both 
neurologically and psychosocially (Duchowny, 1993; Ho-Turner & Bennett, 1999). 
 Relationship between seizure frequency and psychopathology. Seizure frequency 
is another variable that has been examined by researchers to determine its impact on 
psychopathology in patients with epilepsy. Several researchers (e.g., Austin et al., 1992; 
Lambert & Robertson, 1999) found that seizure frequency contributed to behavioral 
difficulties in children with epilepsy. Although to date there is not a sufficient amount of 
data to ascertain the relationship between seizure frequency and the presence of anxiety, 
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there are some data that indicate significant stress and anxiety can escalate the frequency 
of seizures (Vazquez & Devinsky, 2003). 
 Relationship between treatment with antiepileptic drugs and psychopathology. 
Fortunately, antiepileptic drugs often can aid in the management of seizures; 
unfortunately, seizure control alone does not ameliorate the negative affects of epilepsy 
on an individual’s quality of life. Moreover, there is a plethora of research findings that 
support the negative side effects of antiepileptic drugs. Researchers who have studied 
AED treatment in children with epilepsy have found that behavioral side effects are most 
frequently reported. Several researchers (Fiordelli, Beghi, Bogliun, & Crespi, 1993; 
Mendez et al., 1993) found that the use of multiple AEDs (i.e., polytherapy) is associated 
with depression in children with epilepsy. Oguz, Kurul, and Dirik (2002) examined the 
relationship of epilepsy-related factors to anxiety and depression scores in children and 
adolescents, 9-18 years of age, diagnosed with epilepsy. Results indicated that children 
and adolescents who were treated with more than one AED obtained depression and 
anxiety scores that were significantly higher than the children and adolescents who were 
treated with one AED.  
 Currently, the research examining the relationship between seizure-related 
variables and psychopathology is both limited and inconclusive. Mixed results have been 
found on the relationship among a number of seizure related variables and their 
relationship with psychopathology. For example, some researchers have found that 
epilepsy duration, seizure frequency, and polytherapy are related to psychiatric 
disturbances (e.g., Cramer, Blum, & Reed, 2003; Oguz et al., 2002), whereas others have 
not generated significant findings (e.g., Ettinger, Weisbrot, Nolan, Gadow, & Vitale et 
 30
al., 1998). Because there is little conclusive evidence in this area, it is important for 
researchers to determine the impact of specific seizure-related variables on 
psychopathology so that preventative plans may be put in place for children at-risk of 
developing psychiatric difficulties and/or poor HRQL. 
 Neurological Dysfunction and Psychopathology. It has long been hypothesized 
that neurological dysfunction is the primary cause of psychopathology in children with 
epilepsy. Researchers have found that children with neurological disorders have elevated 
levels of psychopathology compared to children with disorders that do not involve the 
nervous system (Lavigne & Faier-Routman, 1992). This may be due, in part, to the reality 
that children with epilepsy have the risk associated with chronic illness and the risk 
associated with a central nervous system disorder, combined. Austin et al. (2002) 
reported that children with epilepsy have a 2.5 times higher risk for psychopathology than 
do children whose chronic illnesses do not involve the central nervous system.  
 Response to epilepsy and psychopathology.  An individual’s response to seizures 
has been compared to the concept of learned helplessness because individuals with 
epilepsy continually experience aversive events (i.e., seizures) over which they have no 
control (Lambert & Robertson, 1999). The seizure episodes may produce extreme fear 
and embarrassment in the individual with epilepsy. Moreover, these negative emotions 
may lead to the development of an external locus of control, which in turn may lead to 
anxiety and/or depression (Hermann, Seidenberg, & Bell, 2000). It is important to note 
that underlying psychiatric illness may contribute to a lower quality of life in children 
with epilepsy.  
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 There are a number of negative emotions that children with epilepsy may 
experience in relation to their neurological condition. For example, fear and anxiety have 
been identified frequently in children newly diagnosed with epilepsy (Austin, Smith, 
Risinger, & McNelis, 1994). Fear and anxiety can present significant emotional burdens 
on children with epilepsy, and these internal emotions often go unnoticed (Shafer, 2002). 
Children diagnosed with seizure disorders may have a number of fears related to their 
epilepsy, including the fear that they will die during a seizure episode, that they will 
suffer brain damage, and/or they will experience a seizure episode in public. Children and 
adolescents may fear an overall loss of control. That is, they may fear a loss of control 
related directly to their medical condition (e.g., over bodily functions during a seizure) as 
well as a loss of control over their social development and relationships (e.g., losing 
friends). 
Comorbid Disorders: Epilepsy and Internalizing Disorders 
 
 Given that epilepsy, anxiety, and depression are all rather common disorders, it is 
not surprising that for a number of children, these conditions coexist (Jackson & 
Turkington, 2005). Therefore, it is problematic that few researchers have examined the 
mechanism of depression and anxiety in epilepsy and even less attention has been 
focused on the treatment of these comorbid disorders (Jackson & Turkington, 2005).  
 There is consensus among several researchers who have found mood disorders 
(e.g., depression) in 12% to 26% of children with epilepsy (Caplan et al., 2005; Oguz et 
al., 2002; Rodenburg et al., 2005). The reported prevalence of mood disorders varies 
depending on a multitude of factors, including instruments used for assessment (e.g., self-
 32
report measures, psychiatric interviews), type of informant (e.g., parent, teacher, and 
child), age range of child, and sample sizes of research studies.  
 The prevalence of comorbid epilepsy and psychopathology is significant, 
especially compared to other chronic illnesses. Davies, Heyman, and Goodman (2003) 
examined the rate of emotional disorders in children with epilepsy, diabetes, and healthy 
children. Records from the Child Benefit Register (CBR) were used to obtain a 
representative sample of 10,316 children between 5 and 15 years of age throughout 
England, Wales, and Scotland. Through data collection from a main caregiver and 
teacher, 67 children with epilepsy (mean age 10 years 2 months), 47 children with 
diabetes (mean age 10 years 4 months), and 10,202 controls (mean age 9 years 11 
months) were identified. 
 The researchers derived DSM-IV psychiatric diagnoses from the Development 
and Well-Being Assessment along with data obtained through clinical interviews. Rates 
of psychiatric disorder were 37% for epilepsy, 11% for diabetes, and 9% for medically 
healthy children (i.e., without chronic medical conditions). Furthermore, parents of 
children with epilepsy reported more emotional and behavioral problems compared to 
parents of children with diabetes and parents of controls. Regression analyses revealed 
that epilepsy was independently associated with all behavioral variables, but this 
association was not found with children with diabetes. Therefore, the researchers 
concluded that emotional and behavioral problems are frequent in children with epilepsy 
and that there is a need for effective mental health services for this population (Davies et 
al., 2003). 
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 Caplan et al. (2005) examined affective disorders, anxiety disorders, and 
suicidality in children with complex partial seizure disorder and absence epilepsy. 
Seizure-related, cognitive, linguistic, family history, social competence, and demographic 
variables and their association with psychopathology also were examined. The study 
involved 171 epilepsy patients; 100 children with complex partial seizures, 71 with 
childhood absence seizures, and 93 medically healthy children, all 5 to 16 years of age. 
Affective and anxiety disorders were present in 33% of children with epilepsy compared 
to only 6% in the healthy group. Furthermore, 20% of children with epilepsy had suicidal 
ideation compared to 9% of children in the healthy group. When examining the 
prevalence broken down by specific disorder, 63% of children had anxiety disorders, and 
26% had comorbid affective/anxiety and disruptive disorders. Caplan et al. (2005) noted 
that only one third of the children who were diagnosed with a psychiatric disorder had 
previously received psychiatric assessment or treatment. This finding highlights the lack 
of attention to psychiatric disorders in children with epilepsy. Even more remarkable, 
results from this study revealed that only one third of children with suicidal ideation 
received any type of psychiatric care. 
 Caplan et al. (2005) found that children with epilepsy who also had affective and 
anxiety disorders obtained significantly higher mean scores on the Child Behavior 
Checklist (CBCL) internalizing and anxiety/depression factor scores. In addition, 
children with epilepsy had significantly higher scores on the Child Depression Index 
(CDI) and the Multidimensional Anxiety Scale for Children (MASC). Furthermore, 
children with complex partial seizures had significantly higher rates of depression and 
comorbid depression and anxiety compared to children with absence epilepsy. 
 34
Conversely, children with absence epilepsy had significantly higher rates of anxiety 
disorders as compared to children with complex partial seizures.  
 In summary, this study was the first to identify a high rate of both affective and 
anxiety disorders (i.e., 33%) and a high rate of suicidal ideation (i.e., 20%) in children 
with epilepsy. Caplan and colleagues reported that only 33% of the children with epilepsy 
identified with affective disorders, anxiety disorders, and/or suicide ideation had received 
mental health services. Because of this finding, along with the high rates of depression, 
anxiety, and suicide in adults with epilepsy, and the age-related increase of suicide in 
adolescence, it is critical that psychopathology is identified and treated early to lessen the 
negative impact of these conditions on children with epilepsy (Caplan et al., 2005). 
 Several meta-analyses were conducted by Rodenburg et al. (2005) to examine the 
types and severity of psychopathology in children diagnosed with epilepsy. These 
researchers examined which types of psychopathology were most prevalent when 
children with epilepsy were compared to children with a different chronic illness to 
ascertain whether psychopathology is generic to chronic illness or specific to epilepsy. 
Children with epilepsy were compared to four control groups (i.e., normative groups, 
healthy study controls, children with a chronic illness, and siblings). A multi-informant 
perspective was utilized, including parent reports, teacher reports, and self-reports. Forty-
six studies met inclusion criteria for the meta-analyses. Data were analyzed from a total 
of 2,434 children with epilepsy, with the average sample size of 65 for children with 
epilepsy. The mean age of children was 10 years, with a range of 4 to 21 years of age 
(Rodenburg et al., 2005). 
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 To examine the severity of psychopathology in children with epilepsy, meta-
analyses of studies comparing children with epilepsy with children from the general 
population were conducted. Results from these analyses revealed medium to large effect 
sizes (i.e., d = .57 to .61) for parent report, teacher report, and self-report. Moreover, 
large effect sizes were consistently found for differences between children with epilepsy 
and normative controls for the whole range of psychopathology. Meta-analyses of total 
behavior problems revealed large effect sizes for parent report and teacher report. Larger 
effect sizes (i.e., d = .45 versus .23) were found on comparisons between children with 
epilepsy and normative controls on externalizing problems compared to internalizing 
problems. Furthermore, meta-analyses of total behavior problems revealed that effect 
sizes for differences between children with epilepsy and healthy study controls were 
medium (i.e., .15) for parent report and teacher report (Rodenburg et al., 2005).  
 These findings confirm that children with epilepsy are at high risk for developing 
psychopathology. These children appear to be vulnerable to the whole range of 
psychopathology, including attention problems, thought problems, and social problems, 
as well as internalizing and externalizing behavior. For parent report, teacher report, and 
self-report, when comparing children with epilepsy to children from normative groups, 
effect sizes were larger for internalizing than for externalizing behavior problems. 
However, effect sizes for externalizing problems were still quite large for parent report 
and teacher report, indicating that externalizing problems also are frequently present in 
children with epilepsy. Researchers concluded that their findings indicated that 
psychopathology in children with epilepsy may be associated partially with generic 
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factors related to chronic illnesses. Therefore, psychopathology may be partly disease-
specific--that is, partly attributed to epilepsy (Rodenburg et al., 2005).  
 It is well documented that there is often a delay in the diagnosis of internalizing 
disorders in children (e.g., anxiety and depression) because they lack overt behavioral 
symptoms that are easy to identify. This problem is the same for children with epilepsy 
experiencing symptoms of anxiety and/or depression. It is common for internalizing 
disorders such as depression and anxiety to manifest differently in children compared to 
adults. That is, children may present with externalizing behaviors, such as irritableness or 
aggressiveness. Therefore, it is important to administer broadband measures to assess a 
wide range of behavioral and emotional difficulties in children with epilepsy.  
Treating Children with Epilepsy and Comorbid Disorders 
 Due to the complexities that may arise when treating epilepsy, the best approach 
for managing pediatric epilepsy is to utilize a disease-based model that distinguishes 
epilepsy syndromes. Accurate diagnosis is essential to enhance medication selection, 
determine length of treatment, and to counsel children and family members regarding the 
overall impact of epilepsy and the likely prognosis. Children who are diagnosed with co-
morbid disorders are likely to be prescribed multiple medications for treatment. This is 
especially problematic for children with epilepsy because there are a number of 
medications prescribed to treat co-morbid disorders that may exacerbate seizures 
(Hulihan, 1997). For instance, a number of over-the-counter cold medications may 
contain epileptogenic compounds that could induce seizure. Furthermore, nonprescription 
anorectics, as well as several antibiotics, have been linked with seizure episodes in 
nonepileptic children (Scheuer, 1992). This emphasizes the importance of close 
 37
monitoring of the patient and the measurement of drug levels. In most cases, children 
may safely use a combination of medications to treat multiple disorders (Hulihan, 1997). 
 The treatment of children with comorbid epilepsy and depression is a challenging 
undertaking. Research findings indicate that depressive episodes in children and 
adolescents tend to be quite lengthy, with an average length of 7 to 9 months. In addition, 
approximately 40% of individuals relapse (i.e., have another depressive episode) within a 
two-year period (Plioplys, 2003). Therefore, the treatment of comorbid affective 
disorders requires a long-term commitment by both patient and caregivers. Although 
medication must be carefully monitored by a physician, antidepressants may be used to 
treat comorbid depression or anxiety in children and adolescents with epilepsy. 
According to Plioplys (2003), somatic treatment and psychotherapy are the main 
psychiatric treatment options for comorbid depression and epilepsy. 
  It is critical to address comorbid psychiatric disorders in patients with epilepsy 
because these comorbid disorders present a profound impact on this population (Davies et 
al., 2003; Devinsky, 2003). The identification, diagnosis, and treatment of comorbid 
psychopathology can be quite challenging. Research findings have supported a 
relationship among comorbid psychopathology, poor functional outcomes, and lower 
quality of life (Devinsky, 2003). However, researchers have only recently begun to focus 
on this association in adults with epilepsy; this relationship in children with epilepsy has 
received even less attention (Hermann et al., 2000). Another difficulty in addressing 
comorbidity in epilepsy is the possibility that the psychopathology may be treatment-
related. For example, the psychopathology may be a consequence of treatment with 
AEDs (Devinsky, 2003).  
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 Another factor that further complicates the treatment of comorbid disorders in 
epilepsy is that very little is known regarding the pathogenic mechanisms underlying the 
comorbidity (Devinsky, 2003). Recent research findings have pointed to a possible 
bidirectional relationship between psychiatric disorders (e.g., depression) and epilepsy; 
however, further research is sorely needed (Kanner & Palac, 2000). Although suitable 
treatment strategies are being developed with use of medications that have mood 
stabilizing effects, the most optimal treatment plans remain unknown (Devinsky, 2003).  
 Due to primary care providers’ lack of clinical expertise in recognizing, 
diagnosing, and treating both epilepsy and psychopathology (Jackson & Turkington, 
2005), collaboration with psychologists and psychiatrists likely would improve 
pharmacological treatment for these patients. One of the most significant barriers to 
receiving appropriate and effective treatment for depression may be that primary care 
physicians and neurologists are reluctant to prescribe antidepressants to their patients. 
This is because all classes of antidepressants are contraindicated in persons with epilepsy, 
and when prescribed, must be used with great caution in this population (Jackson & 
Turkington, 2005). AEDs that effectively control seizures without the adverse effects on 
behavior and cognition, in combination with psychopharmacological treatment to address 
comorbid psychopathology, would be an ideal treatment option for children with epilepsy 
and comorbid psychopathology. 
 Psychiatric side effects can be linked to all types of AEDs used to treat individual 
patients with epilepsy. That is, one group of AEDs has sedation effects such as fatigue 
and cognitive slowing (Ketter, Post, & Theodore, 1999). Another group of AEDs is an 
activating-type that tend to cause activation, weight loss, and possibly antidepressant 
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effects. Because of the correlation between use of AEDs and psychopathology, it is 
critical that knowledge regarding the tolerability of AEDs is increased, possibility 
through clinical trials and/or patient self-report measures. To diagnosis and treat 
comorbidity in children with epilepsy accurately and effectively, the administration of 
AEDs and the potential relationship to psychiatric adverse effects must be considered. It 
is important to differentiate psychopathology that is independent of treatment of an 
underlying illness (e.g., epilepsy) and psychopathology that is a consequence of 
pharmacological treatment of an underlying disorder (Devinsky, 2003). 
 In conclusion, deciding how to treat seizures can be a very complex task. There 
are a multitude of factors that can affect patients and their families’ decisions regarding 
treatment. It is imperative that the patient and family understand both the benefits and 
risks of various treatment options. Depending on past experiences and cultural beliefs, 
people will have different attitudes and beliefs regarding treatment. It is important to 
involve the child in his or her own treatment plan as much as possible. When the team 
(i.e., patient, family members, and practitioners) is able to establish common goals and 
objectives, it is most likely that the treatment will be successful (Shafer, 2002). 
Summary of Psychopathology and Epilepsy 
 Although often unrecognized and untreated, psychopathology (especially anxiety 
and depression) is common in children with epilepsy (Plioplys, 2003). It is unfortunate 
that, to date, the majority of research has focused on psychopathology in adults with 
epilepsy, and studies with children have been sparse. Children with epilepsy may have 
different types of risk factors, but these risk factors are equally significant to the risk 
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factors that adults endure. Just as adults with epilepsy need to adjust to their conditions, 
children also must adapt to the diagnosis and treatment of epilepsy.  
 Epilepsy, compounded with a psychiatric comorbidity, further complicates 
pharmacological and psychosocial treatment planning. The benefits and risks to 
pharmacological treatment in children should be weighed carefully, and this is especially 
true when dealing with comorbidities. Further research is needed to develop effective 
prevention and intervention plans for children with epilepsy and associated 
psychopathology.  
 It is imperative that individuals with seizures are carefully screened by clinicians 
to detect any mood disturbances or other psychopathology (Shafer, 2002). Co-morbid 
psychopathology in children with epilepsy must be identified and treated with 
psychotropic medication and psychotherapy as needed. The high prevalence rates for 
comorbidity in children with epilepsy highlights the need for mental health services in 
pediatric epilepsy clinics. In 2003, the Epilepsy Foundation of America recommended 
that the development of evidence-based mental health treatment specifically for children 
with epilepsy take precedence in the overall management of epilepsy. 
Health-Related Quality of Life and Epilepsy 
 Attention typically has focused on seizure control in patients with epilepsy (Berg 
et al., 2001). However, research findings are accumulating that shed light on the 
tremendous psychosocial impact of epilepsy on patients (Devinsky, 2003; Ronen et al., 
2003). As the primary goal in health care is the attainment of optimal physical and 
psychosocial well-being for patients, the impact of chronic illness on psychosocial 
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functioning should not be overlooked. The cyclical relationship between physical health 
and mental health must be addressed to promote overall health and well-being.  
 Epilepsy can have a significant impact on children’s overall development, 
including learning, behavioral, social, and emotional domains. Historically, epilepsy and 
seizures have been stigmatized (Baker, 2001). This may be due to the fact that self-
control and predictability of behavior is expected in our society, and for individuals who 
experience seizures, this expected behavior is not met. Unfortunately, individuals with 
epilepsy cannot predict when their next seizure will occur, and this uncertainty can make 
others around them uneasy. Given that the average adult does not have an adequate 
understanding of seizure disorders, epilepsy can be a scary condition with which to deal, 
especially for children. This presents a challenging situation for children diagnosed with 
epilepsy, especially in the school setting. 
 Because all children, those with and without epilepsy, have difficulty 
understanding the disorder, it is crucial that educators inform students about epilepsy, 
including causes, symptoms, and treatment options. Fear and uncertainty surrounding the 
condition may lead peers to distance themselves from children with epilepsy. 
Unfortunately, it is quite common for adults and same-age peers who are uninformed 
about epilepsy to segregate children with epilepsy from their peers. When children with 
epilepsy are not permitted to engage in age-appropriate activities with peers, their sense 
of control and overall quality of life may be significantly restricted (Shafer, 2002). The 
development of social relationships is of the utmost importance for children; therefore, 
their exclusion from social activities can severely jeopardize their emotional well-being 
and sense of self. Quality of life is an especially important health outcome to address in 
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children with epilepsy because they appear to be at special risk (Austin et al., 1994). 
Research has shown that epilepsy has a significant negative affect on QOL, with a 
number of factors identified that may cause poor QOL, such as seizure severity, stigma, 
fear, and psychiatric problems (Shafer, 2002).  
Defining Health-Related Quality of Life (HRQL)  
 Health-Related Quality of Life (HRQL) represents the functional effects of an 
illness and its resulting therapy on a patient, as perceived by the individual patient. 
HRQL may be defined as an individuals’ emotional reaction to the illness and their life 
situation, or by their ability to meet personal needs (Baker, 2001). One of the most 
comprehensive definitions is provided by Schipper (1990). In the definition, the 
following five broad domains are covered: physical, occupational, psychological, social, 
and somatic. When treating children with epilepsy, it is imperative that all areas of 
functioning are addressed because all of these areas can significantly impact overall 
functioning. Therefore, an ecological approach to treatment is necessary. One of the chief 
aims of treating children with epilepsy should be to enable them to feel better and to 
improve their function in daily activities.  
 Most clinicians acknowledge that it is critical to incorporate HRQL measures into 
routine clinical practice to ensure that patients with epilepsy receive the best possible 
treatment (Ronen et al., 2003). It has been well-established in the literature that chronic 
medical illnesses, to a certain degree, impact patients’ quality of life (Baker, 2001). 
Additionally, researchers have found that individuals with epilepsy typically experience a 
more severe decline in their quality of life compared to individuals with other types of 
chronic illness. This may be due, in part, to the nature of epilepsy; the uncertainty of 
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when another seizure will occur, how to control the seizures, and when--if ever--they will 
abate (Baker). 
 Quality of life in children with chronic conditions is a relatively new area of 
research (Calaminus, Weinspach, Teske, & Gobel, 2000). However, quality of life data 
has provided important insight for understanding the impact of a chronic illness on 
children’s psychosocial functioning and development (Noll et al., 1999). To assess 
HRQL in children with epilepsy, several groups of researchers have investigated various 
factors that may contribute to a lowered health-related quality of life. Although minimal 
research has been conducted measuring the relationship between epilepsy and HRQL, the 
two areas that researchers have studied include seizure-specific variables, and to a lesser 
extent, psychiatric disorders. The most commonly assessed seizure variables include type 
of seizure, seizure frequency, seizure severity, and age at onset of seizure (Ronen et al., 
2003). However, the relationships between these variables and level of HRQL are only 
moderate. The following sections will review the literature related to both seizure 
variables and psychiatric disorders, and their particular influence on HRQL in children 
with epilepsy. 
Measuring HRQL in Children with Epilepsy 
 Because the chief goal of management of children with epilepsy should be to 
reduce medical and psychosocial complications as much as possible, it is important that 
practitioners are aware of the child’s perception of her/his quality of life. An efficacious 
instrument that measures HRQL is necessary to identify areas of functioning that are 
being negatively impacted so that comprehensive and effective treatment plans can be 
developed. Research has shown that factors specific to seizures (e.g., frequency and 
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severity) are merely one pertinent outcome variable (Ronen et al., 2003). Other 
dimensions, such as social, psychological, and behavioral dimensions also have 
significant impacts on children with epilepsy and their families.     
 There have been several HRQL scales specific to epilepsy developed to measure 
the impact and burden of epilepsy on children (Ronen et al., 2003). However, few 
researchers have studied the score reliability and validity of these measures. It is 
important that HRQL scales measure a multitude of factors, including the child’s 
resilience, co-morbid conditions, and societal or cultural variables. The presence of these 
variables will impact each individual patient to a different degree; however, all have the 
potential to impact significantly patients’ HRQL on a daily basis. Ronen et al. (2003) 
recommend utilizing children’s own perspectives of their HRQL as well as parent 
reports. Once HRQL measures, both generic and epilepsy-specific, have been determined 
to be efficacious, they should be used routinely by clinicians in their daily practices 
(Ronen et al., 2003).   
 Austin et al. (1994) conducted a study examining quality of life in children with 
epilepsy and children with asthma. All children who participated in the study were 
diagnosed with either epilepsy (n = 136) or asthma (n = 134) and were between 8 and 12 
years of age. Additional inclusion criteria also required that the children were currently 
receiving medication for their conditions, had no other chronic physical conditions, and 
had at least average intellectual functioning. Data were collected from the children, their 
guardians, and their teachers through a variety of assessment strategies (e.g., interviews, 
school records, and questionnaires). Participants were compared on four dimensions of 
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quality of life (physical, psychological, social, and school) to determine the specific areas 
that are problematic for children with epilepsy.  
 Data were analyzed via a 2 x 2 between-subjects multivariate analysis of 
covariance with type of illness as the independent variable and length of time since onset 
of illness as a covariate. The most significant finding from the study was that children 
with epilepsy had a more compromised quality of life in the psychological, social, and 
school domains as compared to the group with asthma, despite a later age of disease onset 
and fewer illness episodes for the children with epilepsy compared to the children with 
asthma. Contrarily, children with asthma had a more compromised quality of life in the 
physical domain (Austin et al., 1994).  
 Findings revealed that the physical domain had the lowest correlations with the 
other three domains. Medication side effects also were significantly related to with 
internalizing and externalizing problems at home, and externalizing problems at school. 
The difference in quality of life between groups suggests that difficulties in children with 
epilepsy are not exclusively the result of the chronic condition; poorer HRQL of children 
with epilepsy is at least somewhat specific to seizure disorders. It is hypothesized that 
another aspect of the illness is related to poorer quality of life in the psychological, social, 
and school domains. The researchers hypothesized that whatever caused the epilepsy may 
also directly affect coping behaviors and school achievement (Austin et al., 1994).  
 A limitation to this study was that the physical domain was not measured as 
comprehensively as the psychological, social, and school domains; therefore, future 
research should investigate additional variables such as illness severity and use of 
antiepileptic medications. It also is a challenge for future researchers to ascertain a 
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stronger understanding of the relationship between learning problems and quality of life, 
such as the sequence of events to determine whether these learning difficulties precede or 
follow the emergence of psychological and social problems.  
 These findings suggest that a focus on seizure control will not address the full 
range of problems that children with epilepsy experience. Furthermore, these results 
emphasize the need to ascertain the risk and protective factors for developing problems 
that compromise quality of life. This underscores the need for prevention and 
intervention programs that ameliorate psychological, social, and school performance 
problems in children with epilepsy.  
 Research has revealed that seizure control plays only a minor role in the social 
adjustment of children; therefore, additional factors are likely contributors. Other 
researchers also have concluded that although patients with frequent seizures had poorer 
psychosocial profiles than did those with infrequent or no seizures, important predictors 
of psychopathology and social dysfunction seemed to exist in the patients with refractory 
epilepsy that could not be explained by physical or demographic data (Austin et al., 
1994).  
 Health-related quality of life measures. Both generic and condition-specific 
HRQL scales have been developed to measure quality of life in children. Generic 
measures such as the Child Health Questionnaire (CHQ; Landgraf, Abetz, & Ware, 1996) 
and Pediatric Quality of Life Questionnaire (PedsQL; Varni, Seid, & Kurtin, 2001) were 
developed to assess a broad range of HRQL domains in individuals with chronic 
conditions, irrespective of the specific condition. However, because research has shown 
that children with epilepsy are more susceptible to a poorer QOL than children with other 
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chronic illnesses, use of epilepsy-specific scales may be warranted. Furthermore, a 
generic instrument may lack the sensitivity to detect subtle characteristics of specific 
conditions in a manner that provides meaningful information to patients and professionals 
(Ronen et al., 2003). 
 Disease-specific measures for children have been developed for a number of 
beneficial reasons. For example, disease-specific measures are specifically designed to 
assess areas of functioning that are most likely to be affected by a particular illness. 
Furthermore, they utilize items that are clinically relevant and meaningful for children 
(Quittner, 1998; Spieth & Harris, 1996). Epilepsy-specific HRQL instruments are 
developed to assess characteristics of a particular condition. Therefore, these scales are 
typically more relevant and sensitive to the nuances of epilepsy. However, a drawback to 
the condition-specific scales is that they address a more restricted range of issues than 
generic instruments. Another limitation to the utilization of condition-specific 
instruments is that they often do not have well-documented psychometric properties 
because they are less widely used than generic measures (Ronen et al., 2003). If 
researchers determine that the advantages to utilizing disease-specific HRQL instruments 
outweigh the potential disadvantages, it is important that the psychometric properties 
(validity, reliability) of these measures are assessed so that psychometrically sound 
instruments are used to assess HRQL. 
 Epilepsy-specific HRQL measures for children. Accurately measuring HRQL in 
children with epilepsy can be challenging. Only recently have researchers focused on 
studying epilepsy and its impact on HRQL (Ronen et al., 2003). To garner the most 
useful data when utilizing a HRQL rating scale, it is important to use a measure 
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developed for children because adult HRQL measures are typically inappropriate for use 
in children and adolescents (Carpay & Arts, 1996). Different types of information are 
pertinent depending on the patient’s age. For example, scales developed specifically for 
children focus on social issues and their physical appearance, whereas adult scales focus 
more on financial issues, career issues, and being self-sufficient. Furthermore, HRQL 
measures for children must accommodate the changes that occur throughout children’s 
development, whereas these domains are unnecessary for adult patients.  
 Eiser and Morse (2001) recommend that to assess most accurately children’s 
HRQL, children should rate their own HRQL. Research findings have revealed that 
children identify more items impacting their HRQL than do their own parents. 
Furthermore, young children (i.e., seven years of age) appear to be consistent and 
accurate in their understanding of the items and response options on rating scales, and 
they have demonstrated very good test-retest score reliability (Eiser & Morse, 2001). 
These findings support the effectiveness of utilizing self-report measures to assess HRQL 
in children with epilepsy. 
 It is essential that epilepsy-specific HRQL scales are developed to focus on 
problems relevant to children. For example, it would be advantageous if scales could 
detect subtle changes in the child including evaluation of different therapies. More 
research must be undertaken to identify accurately attributes of HRQL in children with 
epilepsy.  
 One of only two research groups that have addressed this area is Ronen et al. 
(2003). These researchers used separate focus groups for children with epilepsy, ages 6 to 
10 years, and their parents, so that each could discuss their own perceptions of life with 
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epilepsy. Five dimensions were identified: (a) the experience of epilepsy; (b) life 
fulfillment and time use; (c) social issues; (d) impact of epilepsy; and (e) attribution. In 
their follow-up study, 381 children with epilepsy and their parent(s) independently 
completed a 67 item HRQL questionnaire. Factor analyses revealed five HRQL 
dimensions that the children considered most important: (a) interpersonal/social impact; 
(b) areas of worries and concerns; (c) intra-personal/emotional consequences; (d) issues 
of keeping epilepsy a secret; and (e) quest for normality and resilience. Factor analysis of 
the parents' reports of their children's HRQL identified only the first four factors. In 
addition, the parents thought their children were worried as much about the future as 
about present issues whereas in fact the children worried almost exclusively about present 
matters. Based on the results of the factor analyses, the questionnaire was reduced to 25 
items on both the child form and the parent form without sacrificing the integrity of the 
questionnaires. Statistics were computed to determine the psychometric properties of the 
questionnaires. Results showed that the questionnaires were psychometrically robust for 
parents and children 8 years of age and older. Internal consistency, construct-related 
validity, and test-retest reliability were found to be adequate. Scores obtained from the 
matched parent and child were poorly to moderately correlated. 
 In another study, Arunkumar, Wyllie, Kotagal, Ong, and Gilliam (2000) 
examined parent and patient-validated content for quality of life assessment in children 
with epilepsy. The researchers obtained information from both parents of children with 
epilepsy and the children themselves. A total of 80 parents of children with epilepsy (3 
months to 20 years of age) and 48 of the children were asked to share concerns about 
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living with epilepsy in order of importance. These data were helpful in establishing 
questionnaires for use with children and parents (Arunkumar et al., 2000). 
 Gilliam et al. (1997) utilized the parent-proxy generic Child Health Questionnaire 
(CHQ; Langraf et al., 1996) to assess functioning and quality of life in 33 children before 
undergoing epilepsy surgery. Significantly poorer scores were found in the domains of 
emotional impact on parents, time impact on parents, and the general health index. 
Decreased scores also were found for domains of self-esteem, general behavior, and the 
physical function index. Results indicated that the intervention did not allow the children 
who had epilepsy surgery to reach the same levels as healthy controls even though their 
HRQL scores did increase following surgical treatment. However, a significant limitation 
to this study was that it failed to assess which HRQL domains improved after surgery, 
and which, if any, subgroups of patients improved following surgical treatment (Gilliam 
et al., 1997).  
 A different group of researchers (Miller, Palermo, & Grewe, 2003) utilized the 
same parent-proxy CHQ scale to compare 41 children with epilepsy, 4 to 19 years of age, 
to healthy controls. The majority of the children’s seizure disorders were severe, and 
more than one half of the patients had co-morbid neurological impairments. Results from 
this study revealed that the presence of co-morbid disorders and the use of multiple AEDs 
were the strongest predictors for poor HRQL in children with epilepsy. A limitation to 
this study was that HRQL markers unrelated to epilepsy were not used to compare these 
scores for children with epilepsy and scores for the healthy controls. 
 Devinsky, Westbrook, Cramer, Glassman, Perrine, and Camfield (1999) 
conducted a study to assess the risk factors for lowered HRQL in 197 adolescents, 11 to 
 51
17 years of age, with epilepsy. These researchers correlated antiepileptic drug toxicity, 
socio-demographics, academic and social variables, and health-related variables 
(including epilepsy), with self-reported HRQL via the Quality of Life in Epilepsy 
Inventory for Adolescents (QOLIE-AD-48; Cramer, Westbrook, Devinsky, Perrine, 
Glassman, & Camfield, 1999). The variables that were related to lower HRQL included 
older age, lower socioeconomic status, increased seizure severity, and antiepileptic drug 
neurotoxicity. Unfortunately, remediable factors that may have been responsible for the 
lower HRQL in older adolescents and those with a lower socioeconomic status were not 
identified in this study (Devinsky et al., 1999).  
 Despite recent achievements in developing HRQL measures, there is a need to 
improve our understanding of the functional and experiential dimensions associated with 
complex neurodevelopmental disorders (Ronen, Rosenbaum, & Streiner, 2000). It is 
difficult to attribute better or poorer quality of life to the nature of epilepsy alone, when 
so many disparate factors play key roles in people's lives. These factors include, among 
others, a child's resilience, co-morbid conditions, parental well-being, family factors, 
attitudes, and societal/cultural variables. Recent studies have shown that clinical 
symptoms such as seizure frequency and severity, or other biomedical markers, have only 
moderate correlations with HRQL (Ronen et al.). Furthermore, HRQL may change over 
time with the development of the child and the family's accommodation to the situation. 
In addition, we need to learn what truly encompasses comprehensive patient care, define 
the goals of management, and attempt to evaluate the impact of interventions wherever 
possible.  
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 Future assessments should include measures where the items originated from 
children with epilepsy, and allow them to rate their own HRQL. However, parent-proxy 
report measures may be useful in addition to the child's self-assessment. Even though the 
ratings of the child and parent may differ, it may be beneficial to obtain ratings from both 
informants to gain multiple perspectives of the impact of epilepsy (Ronen et al., 2003). 
The combination of self-report and parent responses may help to understand family 
dynamics of coping with epilepsy. In addition, these data may help to identify multiple 
issues that could be addressed through family therapy because a child’s chronic illness 
impacts not only the child, but the entire family. Therefore, future research is needed to 
assess the advantage of using a multi-informant method for measuring health-related 
quality of life in children with epilepsy.  
Summary 
 Pediatric epilepsy is a complex neurological condition with a number of possible 
co-morbid features. Although there is a dearth of research examining comorbid 
psychopathology in children with epilepsy, it is apparent from the existing literature that 
there is a significant relationship between psychopathology (i.e., depression, anxiety) and 
epilepsy in both children and adults. Seizures alone may be difficult to manage as 
treatment with medication presents numerous challenges. There exists the typical 
challenge of medical adherence as well as the potential negative side effects that are 
encountered when using antiepileptic medications. Furthermore, when comorbid 
disorders are present, treatment difficulties are exacerbated. 
 The coping process in epilepsy is not linear; it may vary with different life stages 
and in relation to each patient's unique experiences. When a child is first diagnosed with 
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epilepsy, the child and family are likely to have a variety of emotions and reactions to the 
diagnosis. These initial emotions may include fear, anger, and disbelief, and subsequent 
emotions may involve anxiety and depression (Shafer, 2002). The types and intensity of 
emotions are likely to change over the course of the illness, depending on factors such as 
the severity and frequency of seizures and side effects of medications. Because of the 
multitude of factors that impact the presence of psychopathology and poor health-related 
quality of life, it is imperative that epilepsy management include early assessment and 
treatment of seizures as well as psychosocial problems to assist children in successfully 
coping with their chronic medical condition.  
 It is imperative that researchers ascertain the risk factors that lead to poor health-
related quality of life in children with epilepsy. Knowledge of these factors may help to 
determine effective treatments to enhance the HRQL of children with epilepsy and their 
families. Through the attainment of information related to HRQL of children with 
epilepsy there are many ways that children and their families can be supported. 
Empirically-validated instruments can aid in the detection, assessment, and follow-up of 
issues impacting children with epilepsy and their families. It also is important to 
recognize the need to address opportunities for dissemination, translation of information, 
and implementation of the obtained research findings into clinical pediatric practice.  
 To assess the effect of epilepsy on children, the children’s own perceptions should 
be addressed in addition to their families and teachers, and any other significant persons 
in the child’s environment. When a child is coping with a chronic condition, it impacts 
the child’s entire family. Likewise, the child’s condition may impact his or her 
performance at school, both behaviorally and academically. It is imperative that school 
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faculty and staff (e.g., teachers, psychologists, and administrators) as well as students are 
aware of the child’s condition, including the specific diagnoses, symptoms, and treatment 
plans. Because children spend a significant amount of their day in school, educators are 
in the position to recognize symptoms that may indicate internalizing problems (e.g., 
depression and anxiety) and externalizing problems (e.g., aggression) that may negatively 
impact their levels of success at school. When children with epilepsy and comorbid 
psychopathology are identified early, appropriate interventions may be developed and 
implemented that will help to ameliorate internalizing and externalizing difficulties, as 
well as academic problems. 
 It is critical that healthcare and educational professionals recognize the spectrum 
of issues facing children with epilepsy and become familiar with available resources for 
these children. The ideal model of care for epilepsy stresses collaboration among patients, 
families, primary care physicians, epilepsy specialists, mental health professionals, 
educators, rehabilitation experts, and community resources. Finally, the children 
diagnosed with epilepsy and their caregivers should be counseled regarding the 
associated risks and benefit of various treatment options. 
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Chapter 3 
Method 
Overview 
 This chapter presents the methods for the current study in detail. Characteristics 
of the participants are reviewed, such as inclusion and exclusion criteria, and sampling 
considerations such as sampling scheme and sample size. Next, all procedures for the 
study, in a step-by-step fashion, are thoroughly presented. The research design for the 
study is discussed, as well as the statistical analyses that were conducted to address each 
research question.  
Selection-Eligibility Criteria 
 The purpose of this study was to determine whether seizure type, seizure 
frequency, anti-epileptic drug (AED) treatment, anxious symptomatology, and/or 
depressive symptomatology were correlated with a lowered health-related quality of life 
in children with epilepsy. A central aim of the study was to identify children with 
epilepsy who are most at-risk for poor HRQL based on seizure variables and 
psychopathology. Therefore, children with a variety of types of epilepsy and variability in 
seizure characteristics were invited to participate in this study. 
 The inclusion criteria for participation in the current study were (a) a diagnosis of 
epilepsy confirmed by a pediatric neurologist, (b) chronological age of child between 8 
years, 0 months and 11 years, 11 months at the time of the study, (c) pharmacological 
treatment with AEDs, (d) English proficiency of child and guardian, (e) consent from the 
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children’s parents/guardians, and (f) verbal assent from the children. The age range of 8 
to 11 years was chosen because the researcher was interested specifically in elementary-
school aged children (i.e., pre-adolescence) diagnosed with epilepsy. Additionally, 
adolescent participants were not included because this population would introduce unique 
age-related variables that potentially would confound the findings of the current study. 
Pharmacological treatment with AEDs was an inclusion criterion because the literature 
has shown that AEDs, especially use of multiple AEDs, are correlated with lowered 
health-related quality of life (Devinsky, 2003; First Seizure Trial Group, 1993; Miller et 
al., 2003). This researcher was interested in examining the impact of AEDs, specifically 
the number of AEDs prescribed (i.e., monotherapy or polytherapy) on the presence of 
anxiety and/or depression and health-related quality of life. 
 Exclusion criteria for participation in this study included children diagnosed with 
acquired epilepsy (e.g., due to head injury) and those with epilepsy who were not taking 
any antiepileptic drugs. Furthermore, for purposes of this study, the principal investigator 
was interested in discovering the distinct impact of pediatric epilepsy on depressive 
symptoms, anxious symptoms, and HRQL. Because additional medical or psychiatric 
conditions would likely contribute to depressive symptoms, anxious symptoms, and 
lowered HRQL, children with additional diagnoses were not included in the current 
study. Additionally, children who were prescribed psychotropic medications other than 
anti-depressants and anti-anxiety medication did not meet criteria for the study. 
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Sampling 
Sampling Scheme 
 A non-random, convenience sampling method was used in this study. That is, the 
principal investigator attempted to recruit participants for the current study based on their 
accessibility (e.g., geographic location). This sampling scheme was used because it was 
the most practical sampling scheme given that epilepsy is a relatively low-incidence 
condition.  
Sample Size 
 According to Tabachnick and Fidell (2001), the number of variables in a research 
study, in part, determines the sample size needed to obtain statistically significant results; 
therefore, when utilizing canonical correlation analyses, a rule of thumb in the social 
sciences is to have approximately 10 cases for each variable in the study. However, if 
score reliability is high, then a much lower ratio of cases to variables is adequate. The 
current study examined the relationship between five independent variables and five 
dependent variables utilizing a 5% level of statistical significance and a .80 level of 
statistical power. In view of that, the goal of this study was to obtain data from a 
minimum of 50 parent-child pairs to have sufficient power to obtain statistically 
significant findings. The final sample size obtained in this study was 51 child-guardian 
pairs. 
Instruments 
Demographics and Seizure Variables Questionnaire (DSV Questionnaire) 
A Demographics and Seizure Variables Questionnaire was developed by the 
principal investigator for parents/guardians to complete to obtain information on their 
 58
child diagnosed with epilepsy. This questionnaire was utilized in the study to obtain data 
on specific variables that were statistically analyzed to determine the impact of seizure-
related variables on HRQL, depressive symptoms, and anxious symptoms in children 
with epilepsy. The specific seizure-related variables (i.e., seizure type, seizure frequency, 
and use of AEDs) were included because prior research suggested that these variables 
may negatively impact HRQL in children with epilepsy. Furthermore, demographic data 
were collected so that descriptive information about the population participating in the 
study could be ascertained and presented.  
The following information was gleaned: (a) age of child, (b) gender of child, (c) 
race of child, (d) additional diagnoses of child, (e) type of seizure (i.e., generalized or 
partial), (f) seizure frequency (i.e., 0-5 or 6-12), and (g) treatment with AEDs (i.e., 
monotherapy or polytherapy). The seizure frequency category ranges of 0-5 and 6-12 
were developed based on discussion with a pediatric neurologist. The rationale was that 
seizures that occurred more often than once per month would be considered uncontrolled 
(i.e., intractable) seizures and would introduce another subset of patients with epilepsy. 
The format of this questionnaire consisted of multiple-choice and fill-in-the-blank 
options. There was a total of 10 items; 4 fill-in-the-blank items and 6 multiple-choice 
items. After the questionnaire was developed, a pediatric neurologist reviewed the 
questionnaire to ensure accuracy in the terms used and the wording of the items. The 
questionnaire took guardians approximately five minutes to complete. The Demographics 
and Seizure Variables Questionnaire is presented in Appendix A. 
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Behavior Assessment System for Children, Second Edition (BASC-2; Reynolds & 
Kamphaus, 2004) 
 The Behavior Assessment System for Children, Second Edition (BASC-2), is a 
broadband measure that consists of a variety of items and scales that assess internalizing 
and externalizing domains of behavioral/emotional problems, as well as social and 
adaptive competencies. The BASC-2 has both clinical and adaptive scales. The clinical 
scales include: Externalizing Problems (hyperactivity, aggression, and conduct 
problems), Internalizing Problems (anxiety, depression, and somatization), School 
Problems, Attention Problems, and Learning Problems. The adaptive scales include: 
Adaptive Skills (adaptability), Social Skills (leadership), and Study Skills.  
 The BASC-2 includes a total of six forms: self, parent, and teacher measures for 
young children (ages 6 through 11), and self, parent, and teacher measures for 
adolescents (ages 12 through 21). Research has shown that caregivers and teachers are 
not always aware of the negative effects of an illness on their child, which is evidenced 
by discrepancies found between child and parent reports (Merrell, 1999). Therefore, both 
the child self-report form (BASC-SRP-C) and the parent form (BASC-PRS-C) were 
completed independently.  
 Moreover, there are significant differences among children with anxiety alone, 
depression alone, and co-morbid anxiety and depression; therefore, it is imperative to 
differentiate between anxiety and depression (Brady & Kendall, 1992). Given the co-
morbidity of both anxiety and depression in epilepsy, it is necessary to assess anxiety and 
depression in children with epilepsy to develop effective treatment plans. The BASC-2 
provides validity indicators (F, Response Pattern, and Consistency) that make the 
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interpretation of clinical scale elevations more meaningful. Furthermore, the BASC-2 
separates anxiety and depression constructs into two separate scales. There is no item 
overlap between these two scales, and this allows for a greater opportunity for differential 
diagnosis (Kamphaus & Frick, 1996). For purposes of the current study, the anxiety and 
depression scales from the BASC-2 were of most interest. 
 The BASC-2 produces T-scores, which describe distance from the mean, and 
percentiles, which describe rarity. The BASC-2 has been normed for a general population 
as well as clinical populations. Clinical norms are useful when the child’s problems are 
extreme compared to the general population. Therefore, clinical norms help to avoid 
ceiling effects for children who have significant adaptive and/or behavioral problems. In 
addition to general norms and clinical norms, the BASC-2 also has gender-based norms. 
Gender-based norms help identify children whose self-report scores are rare for their age 
and gender (Reynolds & Kamphaus, 2004).  
 The BASC-2 generates two interpretive ranges (i.e., at-risk and clinically 
significant) for composite scales and subscales based on T scores obtained using norms. 
Typically, T scores ranging from 60 to 69 on the clinical scales are considered to be in the 
“at-risk” classification range indicating the potential of developing a problem that 
requires careful monitoring. T scores of 70 and above on the clinical scales are 
considered to be in the “clinically significant” range. Scale scores in the clinically 
significant range indicate a high level of maladjustment. The BASC-2 is reported to be a 
comprehensive and psychometrically sound assessment instrument (Flanagan & 
Esquivel, 2006). 
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 The Behavior Assessment Scale for Children - Self-Report of Personality (BASC-
SRP-C) consists of 152 items and is designed for use with children 8 to 11 years of age to 
provide insight into children’s thoughts and feelings. The BASC-SRP-C takes children 
approximately 30 minutes to complete. The BASC-SRP-C is written at a first-grade 
reading level; therefore, children as young as six years of age should be able to complete 
the measure independently or with minimal assistance. Furthermore, the SRP form 
contains validity scales to aid in determining the quality of the data collected. 
 The BASC-SRP-C is a well-developed broadband self-report measure with strong 
psychometric properties (Merrell, 1999). Analyses conducted with data from the 
standardization sample revealed that the median internal consistency reliability 
coefficients of the scale scores were in the low .80 range. Furthermore, the median 
coefficients for the composite scores were in the mid .90 range, and the test-retest 
reliability coefficients were in the mid .80 range at one month intervals (Merrell, 1999).  
In the current sample, the internal consistency reliability coefficient of the scale scores on 
the BASC-SRP-C Anxiety subscale was 0.72 and the Depression subscale was 0.87. 
 The Behavior Assessment System for Children – Parent Rating Scale (BASC-
PRS-C), is completed by parents or guardians and takes approximately 10-20 minutes to 
complete. The BASC-PRS consists of 134 to 160 items that measure adaptive and 
problem behaviors in the home and community setting. Items on the PRS are rated by 
using a 4-point Likert-type scale ranging from 0 (never) to 3 (almost always). To 
complete the PRS, a fourth-grade reading level is required. It is reported in the BASC-2 
manual that the individual PRS scale and composite scores yield good reliability 
coefficients (.80), except for the Adaptability, Conduct Problems, Hyperactivity, and 
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Somatization scales. Fortunately, for purposes of this study, the former scales were not of 
specific interest. A number of criterion-related and construct-related validity studies 
indicate that the PRS scores yield adequate validity (e.g., Doyle, Ostrander, Skare, 1997; 
Kamphaus & Frick, 1996). In the current sample, the internal consistency reliability 
coefficient of the scale scores on the BASC-PRS-C Anxiety subscale was 0.72 and the 
Depression subscale was 0.87.  
 Health-Related Quality of Life Questionnaire (HRQL; Ronen et al., 2003) 
 The Health-Related Quality of Life questionnaire (HRQL; Ronen et al., 2003) 
was used to assess the quality of life for children diagnosed with epilepsy. There were 
two versions of this questionnaire utilized in the current study: a child questionnaire and a 
parent questionnaire. The child questionnaire was developed for children 6 to 15 years of 
age. This measure was designed to assess a child’s quality of life in multiple domains. 
The child questionnaire contains five subscales: (a) interpersonal/social, (b) present 
concerns, (c) intrapersonal/emotional, (d) secrecy, and (e) normality. The parent 
questionnaire also contains five subscales: (a) interpersonal/social, (b) present concerns, 
(c) future concerns, (d) intrapersonal/ emotional, and (e) secrecy.  
 Both the parent form and the child form have 25 items. All items on the 
questionnaires utilize a 4-point Likert-type scale, ranging from “really true” to “sort of 
true” for two contrasting statements. An example of an item is, “Some kids with epilepsy 
feel that other kids treat them differently” but “Other kids with epilepsy feel they are 
treated the same as everyone else.” The individual is instructed to circle the statement 
that is most like them, and then choose whether the one statement is “really true” or “sort 
of true” for them. The scores for each subscale range from 5 to 20, with lower scores 
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indicating more compromised HRQL. Both parent and child HRQL questionnaires are 
reported by the developer to take approximately five minutes to complete. 
 The HRQL questionnaire is one of only two disease-specific health-related quality 
of life scales that uses a self-response questionnaire that has been found to have sound 
psychometric measures. Furthermore, the HRQL is the only measure that has parallel 
questionnaires for both the parent/guardian and the child to complete independently. 
Ronen et al. (2003) assessed the psychometric properties of the HRQL questionnaire. A 
total of 381 children and 424 parents/guardians participated in the study. All child 
participants were between 8 and 15 years of age. Results revealed that scores from the 
HRQL questionnaire yielded good internal consistency, test-retest reliability, and 
construct-related validity (Ronen et al.). Cronbach’s alpha demonstrated adequate 
internal consistencies (> 0.70) for scores yielded for all scales except the normality 
subscale in the self-report scale (i.e., 0.63) and the present worries subscale in the parent-
proxy scale (i.e., 0.64). In the current sample, the internal consistency reliability 
coefficient of the five subscale scores on both the HRQL – Child Form and Parent Form 
were adequate. Cronbach’s alpha for scores on the HRQL- Child Form were as follows: 
Social (0.87), Present (0.90), Emotion (0.91), Secrecy (0.90), and Normalcy (0.91). On 
the HRQL – Parent Form, the five subscale scores revealed the following score reliability 
coefficients: Social (0.87), Present (0.88), Future, (0.79), Emotion (0.76), and Secrecy 
(0.80). 
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Procedures 
 Prior to the start of the research study, approval for the proposed study was 
obtained from the University of South Florida Institutional Review Board to ensure the 
ethical treatment of all participants. The principal investigator obtained the contact 
information (e.g., telephone number) of a pediatric neurologist in the west central Florida 
region. This contact information was obtained by the principal investigator through a 
psychologist in the same geographical region who was participating on the principal 
investigator’s dissertation committee and had a working relationship with a pediatric 
neurologist in the region. The pediatric neurologist was contacted via telephone to 
provide information regarding the goals and objectives of the study. The principal 
investigator requested permission from the participating pediatric neurologist to hand-
deliver packets to his practice to be distributed by the office manager to the parent-child 
pairs who met all inclusion criteria.   
 In January 2008, the principal investigator sought and obtained approval from 
Wayne State University’s Institutional Review Board to add a Children’s Hospital 
located in the Midwestern United Sates as a second data collection site. The principal 
investigator contacted a pediatric neurologist at the Children’s Hospital via electronic 
mail and written letter to provide information regarding the goals and objectives of the 
study. The principal investigator requested permission from the pediatric neurologist to 
hand-deliver packets to his clinic within the Children’s Hospital to be distributed by the 
office manager to the parent-child pairs who met all inclusion criteria.   
 After verbal and/or written consent was obtained from the above-referenced 
pediatric neurologists, packets (i.e., forms enclosed within a sealable manila envelope) 
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were generated for parent-child pairs. The packets for the two sites consisted of the same 
type of information; however, the consent process/requirements of the two sites differed 
and therefore there was a slight variation in the packets for the two sites. Packets for the 
site in the Southwestern United States consisted of the following documents: a cover 
letter and assent form for the child participant (see Appendix B) and a cover letter and 
consent form for the guardian participant (see Appendix C). Additionally, the packets 
included each of the following measures: Demographics and Seizure Variables (DSV) 
questionnaire to be completed by the guardian, Behavior Assessment System for Children 
– Parent Rating Scale (BASC-PRS; Reynolds & Kamphaus, 2004), Behavior Assessment 
System for Children – Self Report of Personality, child form (ASC-SRP-C; Reynolds & 
Kamphaus, 2004), Health-Related Quality of Life (HRQL; Ronen et al., 2004) – parent 
form (see Appendix D), and Health-Related Quality of Life (HRQL; Ronen et al., 2004) 
– child form (see Appendix E). The documents included in the packets for the Children’s 
Hospital in the Midwestern United States were the same as stated for the Southeastern 
United States site with the following exceptions: instead of an assent form (Appendix B) 
an assent oral script was utilized (see Appendix F), and in lieu of the parental consent 
form (Appendix C), an information sheet was provided to guardian participants (see 
Appendix G). The instruments were presented in counter-balanced order; that is, one half 
of the packets had the BASC-2 rating scale first, followed by the HRQL scale and the 
other one half were in reverse order. 
 Two cover letters were developed; one for the child participant and one for the 
parent/guardian participant. In age-appropriate language, each cover letter reviewed the 
purpose and goals of the study, and provided detailed instructions regarding how to 
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complete the questionnaires and rating scales. The instructions emphasized that all forms 
should be completed independently, and specific guidelines were provided in the 
parent/guardian cover letter (and information sheet) regarding assisting their child with 
completing the forms. For example, the parent/guardian could clarify, as needed, any 
item for which the child requested clarification; however, the parent/guardian should not 
influence the child’s responses. That is, permission was given to read items from the 
questionnaires out loud to the child if needed; however, the items were to be read 
verbatim. Both cover letters explained that all data collected would be confidential and 
would only be used for research purposes. In the event that participants had any questions 
or concerns regarding the research study, the cover letters provided the principal 
investigator’s contact information (i.e., telephone number and electronic mail address) so 
that additional information could be provided to participants as requested.  
 Finally, the cover letters included a description of an incentive for completing and 
returning all forms in the packet. All parent-child pairs that completed and returned the 
assent and consent forms, Demographics and Seizure Variables Questionnaire, and rating 
scales were eligible to receive a $100 Visa gift card through a random drawing that was 
completed at the end of the data collection period. The cover letter requested that the 
parent-child pair review the materials in the packet, and if they chose to partake in the 
study, to sign the consent and assent forms and include them in the packet to be returned 
to the office manager in the pediatric neurologist’s office.  
 Information was collected from participants in a pediatric neurologist’s office in 
the Southeastern United States and a pediatric neurology clinic housed in a Children’s 
Hospital in the Midwestern United States. When parent-child pairs arrived for their 
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regularly scheduled appointments with the pediatric neurologists, they were asked by the 
office manager if they were willing to participate in a research study that required them 
(parent and child) to take approximately 40 minutes to fill out several forms related to the 
child’s illness. If they consented, they then were given a packet and were asked to read 
through the materials. The materials instructed the participants to sign the consent and 
assent forms and to complete the questionnaire and rating scales in the packet prior to 
their appointment with the pediatric neurologist. The forms were filled out in the 
reception area while they were waiting to meet with the pediatric neurologist. After 
materials were completed independently by the parent and child, they were sealed in a 
manila envelope by the parent, and the office manager collected and held the completed 
packets at the pediatric neurologist’s office until the principal investigator collected the 
completed packets. After approximately two months of data collection, an adequate 
number of participants had not be accessed (i.e., less than 30 completed packets); 
therefore, a pediatric neurologist practicing within a non-profit Children’s Hospital was 
contacted to obtain access to additional participants. The principal investigator was 
granted access to recruit patients from this neurologist’s practice which generated 47 
additional participants for the current study.  
 All data obtained from participants were kept confidential and were accessible 
only to the principal investigator. All forms in each packet had identification numbers to 
match parent and child forms/responses in the event that the pair of parent-child forms 
became separated. The identification numbers were arbitrarily created by the principal 
investigator. The identification number for each parent-child pair was printed on the 
individual forms to ensure anonymity; therefore, no identifying information was collected 
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from participants. That is, in each packet, both guardian and child instruments had the 
same code number (e.g., 001). Approximately 50 packets were delivered by the principal 
investigator to the participating pediatric neurologists’ clinic. The office managers at each 
clinic collected the completed packets and made a notation (e.g., asterisk) in the child’s 
private medical file indicating that they returned the completed packet. At the conclusion 
of the study, the principal investigator provided the neurologists’ office managers each 
with a $100 Visa gift card, and the office managers randomly selected an individual who 
had participated in the study to receive the gift card. The office manager selected a name 
from those marked with a notation in their medical file indicating that they had 
participated in the study. This procedure allowed all participants to remain anonymous, as 
the neurologists and office managers were the only persons who were privy to the 
participants’ identities and contact information. All completed packets were stored in a 
locked file cabinet that was accessible only to the principal investigator. Once all data 
were collected, the principal investigator conducted statistical analyses, interpreted the 
results, and presented the findings.  
 For participants at the Southeastern United States site, any child participants 
obtaining depression and/or anxiety scores in the “at-risk” or “clinically significant” 
range on the BASC-2 were notified of their increased risk for psychopathology (i.e., 
depression and/or anxiety). The participants’ code numbers and BASC scores in these 
elevated ranges were disclosed to the neurologist’s office manager within 24 hours of 
scoring the BASC data. In turn, the office manager contacted the guardian participant to 
relay this information so the guardian could make an informed decision regarding the 
attainment of appropriate mental health services for their child. Similarly, all participants 
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recruited from the Midwestern United States site were provided with an outpatient 
psychotherapy referral form from the Department of Psychiatry and Psychology at the 
recruitment site (i.e., children’s hospital) in the event that they requested outpatient 
services. 
Research Design 
 The current study utilized an exploratory, non-experimental research design, also 
known as a correlational research design. This design was used because the principal 
investigator was interested in determining the statistical association between two or more 
variables. This study utilized a survey method to collect quantitative data from 
participants. Survey methods are typically used to gather large amounts of data about a 
construct when there is little empirical data available (Bordens & Abbott, 1996). The 
survey method encompassed a multi-informant approach whereby both self-report and 
parent-report were utilized to obtain data from multiple viewpoints. Specifically, the 
child with epilepsy and his or her guardian completed the assessment instruments (i.e., 
rating scales). This multi-informant approach was utilized because research shows that it 
is advantageous to collect data from multiple sources. Furthermore, in applied research, 
the multi-informant approach is characteristic of quality research designs (Holmbeck et 
al., 1998).  
Data Analyses 
Descriptive Statistics 
Once all questionnaires and rating scales were completed by the participants and 
returned to the researcher, the data were analyzed. Descriptive statistics included the 
following: mean, median, standard deviation, and skewness and kurtosis of individual 
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participants’ scores across rating scales and questionnaires. In addition, descriptive 
statistics were computed for the participants’ demographic information. No extreme 
outliers were discovered in the data. The descriptive statistics are illustrated 
quantitatively in Table 1. 
Variables 
 Independent variables. The independent variables in this study were symptoms of 
anxiety and depression (as measured by the BASC-2) and seizure-related variables. The 
seizure-related variables were type of epilepsy, seizure frequency, and use of antiepileptic 
drugs (i.e., monotherapy or polytherapy). 
 Dependent variables. The dependent variables in this study comprised health-
related quality of life subscale scores, as measured by the Health-Related Quality of Life 
(HRQL) questionnaire. The five subscale scores for the self-report measures were social, 
present, emotional, secrecy, and normalcy factors. For the parent report measure, the five 
subscales consisted of social, present, future, emotional, and secrecy factors. Each 
individual subscale ranged from 5 to 20, with higher scores indicating better health-
related quality of life. 
Inferential Statistics 
Canonical correlation analysis. Canonical correlation is a procedure that allows 
researchers to examine the relationship between two sets of variables (Thompson, 1984). 
The linear correlation between the two sets of latent (i.e., not directly observed; inferred) 
variables is maximized with a canonical correlation analysis. Sets of variables are 
combined to produce a predicted value that has the highest correlation with the predicted 
value of the other (second) set of variables (Thompson, 1984). That is, canonical 
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correlation analyses allowed this researcher to determine which combination of seizure-
related variables and psychopathology variables best correlate with health-related quality 
of life variables in children with epilepsy.  
More than one linear correlation relating two sets of variables may exist, with 
each correlation representing a different dimension by which the independent set of 
variables is related to the dependent set. Specifically, the linear correlation relating the 
two sets of variables is termed a canonical function and the number of canonical 
functions that can be generated for a given data set is equal to the number of variables in 
the smaller of the two variable sets. Because there were five independent variables and 
five dependent variables in the child data set and the parent data set, the number of 
possible canonical functions in each set was five.  
 There are several assumptions for canonical correlation analysis. First, there is the 
assumption of linearity that posits that the correlation coefficient between any two 
variables is based on a linear relationship, and the canonical correlation is the linear 
relationship between the variates. It is unlikely that this assumption can ever be truly 
confirmed; however, canonical correlation analysis is robust to small deviations from this 
assumption (Thompson, 1984). Nevertheless, a bivariate scatterplot was used to 
determine if there is curvature in the relationship between each independent variable and 
dependent variable. If significant curvature was found, then the corresponding variable 
would have been transformed.   
 Second, in canonical correlation analysis, it is assumed that there is multivariate 
normality, which can be assessed, in part, by ensuring that each variable has univariate 
normality. That is, if univariate distributions are not normal, the multivariate distribution 
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is not normal; however, if all univariate distributions are normal, it is still possible that 
the multivariate distribution is not normal. Nevertheless, canonical correlation can 
accommodate metric variables without the strict assumption of normality (Osborne & 
Waters, 2002). Third, the assumption of the absence of multicollinearity indicates that 
there is no redundancy in the independent variables such that a relationship does not exist 
between them (Osborne & Waters, 2002). Finally, it is important to note that a significant 
limitation to canonical correlation analyses is that relationships can be determined, but 
the underlying causal mechanism cannot be ascertained.  
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Chapter 4 
 
Results 
 
Treatment of the Data 
 
 The data were entered into an Excel spreadsheet by the researcher and verified by 
a colleague (i.e., a clinical psychology graduate student) following the completion of all 
forms and questionnaires. Each score was entered for every participant on each individual 
item. Missing data were coded as a blank space in the Excel document while single items 
with multiple responses were averaged and the mean score was inputted. The researcher 
and a clinical psychology graduate student checked the data by randomly selecting 
participants’ identification numbers and matching the data in the database to the entrees 
completed by hand. Additionally, extreme values were checked across each participant 
for each item to ensure that data were entered correctly. The final sample size of this 
study was 51 child-guardian pairs; no cases were removed from the analysis due to 
extreme outliers or incomplete data. Inter-rater agreement was 100%. 
Demographics 
After all data were transferred from the Excel spreadsheet into an SPSS data 
editor file, the data were analyzed. Descriptive statistics were computed for participants’ 
demographic information (see Table 1). All demographic information collected in the 
current study was obtained through parent self-report measures.  
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Independent Variables  
Among the dichotomous variables, gender was coded as “1” for males and “2” for 
females. Medical insurance was coded as “1” for private insurance and “2” for Medicaid. 
Regarding seizure type, generalized seizures were coded as “1” and partial seizures were 
coded as “2.” Child participants with 0 to 5 seizures within the last 12 months were coded 
as “1” and those with 6 to 12 seizures within the last 12 months were coded as “2.” 
Finally, child participants treated with one AED were coded as “1” and those treated with 
more than one AED were coded as “2.” The continuous variable (i.e., age of child) was 
measured in years and months. 
The mean age of the children participants was 9 years 5 months (SD = 1 year 8 
months). The youngest child participant was 8 years, 0 months of age whereas the oldest 
child participant was 11 years, 11 months of age. Regarding gender of the child 
participants, 29 (56.9 %) were identified as male and 22 (43.1 %) identified as female. 
Twenty-eight (54.9 %) families identified themselves as White, 11 (21.6 %) identified as 
African American, 4 (7.8 %) identified as Hispanic, and 8 (15.7 %) identified themselves 
as mixed race.  
Information regarding participants’ medical insurance was obtained in an effort to 
infer the socioeconomic status of families participating in the current study. These data 
were dummy coded; families with private medical insurance were coded as “1” and 
families with medical insurance through Medicaid were coded as “2.” Based on 
participants self-report, 18 (35.3 %) families had private medical insurance. The 
remaining 33 (64.7 %) families reported that they had insurance through Medicaid. 
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Twenty-one (41.2 %) parent participants reported that their child’s seizures were 
generalized seizures, with 30 (58.8 %) parents reporting that their child experienced 
partial seizures. Regarding seizure frequency, 28 (54.9 %) parent participants indicated 
that their child experienced between zero and five seizures within the last 12 calendar 
months. Twenty-three (45.1 %) parent participants reported that their child had 
experienced between 6 and 12 seizures within the last 12 calendar months. Finally, 34 
(66.7 %) parent participants indicated that their child currently was prescribed a single 
anti-epileptic medication (i.e., monotherapy) compared with 17 (33.3 %) parent 
participants who indicated that their child was prescribed multiple anti-epileptic 
medications (i.e., polytherapy). 
Table 2 presents descriptive data for child self-report and parent report on BASC-
2 and HRQL measures. Means, standard deviations, skewness, and kurtosis are reported 
for each individual variable. The BASC-2 generates two interpretive ranges (i.e., at-risk 
and clinically significant) for composite scales and subscales based on T scores obtained 
using norms. Typically, T scores ranging from 60 to 69 on the clinical scales are 
considered to be in the “at-risk” classification range indicating the potential of developing 
a problem that requires careful monitoring. T scores of 70 and above on the clinical scales 
are considered to be in the “clinically significant” range. Scale scores in the clinically 
significant range indicate a high level of maladjustment. Scores below 60 are considered 
to be in the “normal” range and do not indicate maladjustment.  
In the current study, child participants’ ratings of anxious symptoms (as measured 
on the BASC-2) had a mean score of 54.9 (SD = 8.8), with scores ranging from 37 to 71. 
Self-report scores on depressive symptoms (as measured by the BASC-2) had a mean 
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score of 54.7 (SD = 9.1) and a range of 38 to 73. Parent-report of anxious symptoms in 
the child participant (as measured on the BASC-2) had a mean score of 54.9 (SD = 8.8), 
with scores ranging from 37 to 71. Parent-report scores on depressive symptoms (as 
measured by the BASC-2) had a mean score of 54.7 (SD = 9.1) and a range of 38 to 73. 
Dependent Variables  
The outcome measures for this study were health-related quality of life (HRQL) 
rated by child self-report and parent-report. Specifically, there were subscale scores for 
the following five HRQL measures as rated by self report: (a) social concerns, (b), 
present concerns, (c) emotional concerns, (d) secrecy issues, and (e) normalcy issues. The 
scores for each subscale range from 5 to 20, with lower scores indicating more 
compromised HRQL. Descriptive statistics for the HRQL self-report measure were as 
follows: self-report of social concerns (as measured on the HRQL) had a mean score of 
15.2 (SD = 3.38) and a range from 8 to 20. Present concerns had a mean score of 16.1 
(SD = 3.49) and a range from 9 to 20. Emotional concerns had a mean score of 15.4 (SD 
= 3.60) and a range from 8 to 20. Secrecy issues had a mean score of 15.4 (SD = 3.34) 
and a range from 9 to 20. Finally, normalcy issues had a mean score of 15.7 (SD = 3.48) 
and a range from 9 to 20. 
The HRQL parent form had five subscales as well, consisting of (a) social, (b) 
present, (c) future, (d) emotional, and (e) secrecy. Descriptive statistics for the HRQL 
parent-report measure were as follows: parent-report of social concerns (as measured on 
the HRQL) had a mean score of 15.3 (SD = 3.99) and a range from 6 to 20. Present 
concerns had a mean score of 15.5 (SD = 3.88) and a range from 7 to 20. Future concerns 
had a mean score of 15.7 (SD = 3.66) and a range from 8 to 20. Emotional concerns had a 
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mean score of 15.3 (SD = 3.89) and a range from 7 to 20. Finally, secrecy had a mean 
score of 15.3 (SD = 4.25) and a range from 6 to 20. 
 
Table 1 
Descriptive Statistics for Participants (n = 51) 
 
Variable 
 
 (%) 
 
 
Age   
     8.0 – 8.11 23.5  
     9.0 – 9.11 29.4  
     10.0 – 10.11 25.5  
     11.0 – 11.11 21.6  
Gender   
     Male 56.9  
     Female 43.1  
Race   
     White (Non-    
     Hispanic) 
 
54.9 
 
     African        
     American 
 
21.6 
 
     Hispanic/Latino   7.8  
     Asian American   0.0  
     Native American   0.0  
     Mixed-Race/Other 15.7  
Medical Insurance 
     Private 
     Medicaid 
     None 
Seizure Type 
     Generalized 
     Partial 
Number of Seizures 
     0 – 5 per year 
     6 – 12 per year 
Anti-epileptic Drugs 
     Monotherapy 
     Polytherapy 
 
35.3 
64.7 
  0.0 
 
41.2 
58.8 
 
54.9 
45.1 
 
66.7 
33.3 
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Table 2 
Means, Standard Deviations, Skewness, and Kurtosis for Participant Ratings (n = 51)    
 
Variable 
 
Self-Report 
 
M 
 
SD 
 
Skewness 
 
Kurtosis 
 
 
AnxietyCH 54.9 8.78 -0.33 -0.66 
 
DepressionCH 54.7 9.15 0.24 -0.81 
 
SocialCH 15.2 3.38 -0.51 -0.67 
 
PresentCH 16.1 3.49 -0.52 -1.05 
 
EmotionCH 15.4 3.60 -0.21 -1.33 
 
SecrecyCH 15.4 3.34 -0.27 -1.11 
 
NormalcyCH 15.7 3.48 -0.33 -1.05 
     
Parent-Report     
AnxietyPR 54.9 8.33 0.38 -0.87 
 
DepressionPR 57.5 7.16 0.36 0.35 
 
SocialPR 15.3 3.99 -0.56 -0.70 
 
PresentPR 15.5 3.88 -0.51 -0.94 
 
FuturePR 15.7 3.66 -0.53 -0.79 
 
EmotionPR 15.3 3.89 -0.52 -0.98 
 
SecrecyPR 15.3 4.25 -0.47 -1.12 
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Defining Characteristics of BASC-2 Anxiety Scale: Child Self-Report 
Anxiety and Seizure Type  
 Anxious symptoms, as measured by the BASC-2 Child Form, had an overall 
mean of 56.00 (SD = 10.58) for children with generalized seizures and 54.13 (SD = 7.37) 
for children with partial seizures. These scores did not indicate a statistically significant 
difference in anxiety scores based on type of seizure F(1, 49) = 0.55, p = .461). The 
effect size for the difference in mean scores between children with generalized and partial 
seizures was small for self-report (d = 0.011). The skewness and kurtosis values indicated 
a fairly normal distribution of scores for children with generalized and partial seizures 
(skewness = -0.42, -0.49; kurtosis = -0.88, -0.73, respectively). 
Anxiety and Seizure Frequency 
Anxious symptoms, as measured by the BASC-2 Child Form, had an overall 
mean of 51.68 (SD = 8.38) for children with seizures 0 to 5 times in the last 12 months 
and 58.83 (SD = 7.72) for children with 6 to 12 seizures within the last year. The effect 
size for the difference in mean scores between children with more and less seizures was 
small for self-report (d = 0.17). These scores indicated a statistically significant 
difference between self-report of anxiety and frequency of seizures, with children with 
more seizures (5-12 within the last year) indicating increased anxiety symptoms, F(1, 49) 
=  9.85, p < .01. The skewness and kurtosis values indicated a fairly normal distribution 
of scores for children with less frequent seizures (i.e., zero to five seizures in last year) 
and children with more frequent seizures (i.e., 6 to 12 seizures in last year) (skewness =   
-0.27, -0.45; kurtosis = -1.03, -0.40, respectively). 
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Anxiety and Use of AED 
 Anxious symptoms, as measured by the BASC-2 Child Form, had an overall 
mean of 52.09 (SD = 7.85) for children treated with monotherapy and 60.53 (SD = 7.95) 
for children treated with polytherapy. These scores indicated a statistically significant 
difference between self-report of anxiety and treatment with AEDs, with polytherapy 
indicating increased anxiety symptoms, F(1, 49) = 12.97, p < .001. The effect size for the 
difference in mean scores between children treated with monotherapy versus polytherapy 
was small for self-report (d = 0.210). The skewness and kurtosis values indicated a fairly 
normal distribution of scores for children with monotherapy and polytherapy (skewness = 
-.32, -1.13; kurtosis = -.61, 1.00, respectively).  
Defining Characteristics of BASC-2 Anxiety Scale: Parent Report 
Anxiety and Seizure Type 
 Anxious symptoms, as measured by the BASC-2 Parent Form, had an overall 
mean of 58.10 (SD = 9.34) for children with generalized seizures and 52.67 (SD = 6.84) 
for children with partial seizures. These scores indicated a statistically significant 
difference between parent-report of anxiety and type of seizure, with parents’ indicating 
increased anxiety symptoms for children with generalized seizures, F(1, 49) = 5.75, p < 
.020. The effect size for the difference in mean scores between children with generalized 
and partial seizures was small for parent report (d = 0.11). The skewness and kurtosis 
values indicated a fairly normal distribution of scores for children with generalized and 
partial seizures (skewness = -0.05, 0.34; kurtosis = -1.43, -0.50, respectively). 
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Anxiety and Seizure Frequency 
 Anxious symptoms, as measured by the BASC-2 Parent Form, had an overall 
mean of 51.07 (SD = 6.57) for children with seizures 0 to 5 times in the last 12 months 
and 59.57 (SD = 7.95) for children with 6 to 12 seizures within the previous year. These 
scores indicated a statistically significant difference between parent report of anxiety and 
frequency of seizures, with children with more seizures (5-12 within the last year) 
indicating increased anxiety symptoms, F(1, 49) = 17.47, p < .001. The effect size for the 
difference in mean scores between children with more and less seizures was small for 
parent report (d = 0.26). The skewness and kurtosis values indicated a fairly normal 
distribution of scores for children with less frequent seizures (i.e., zero to five seizures in 
last year) and children with more frequent seizures (i.e., 6 to 12 seizures in last year)  
(skewness = 0.90, -0.28; kurtosis = 0.37, -0.58, respectively). 
Anxiety and Use of AEDs 
 Anxious symptoms, as measured by the BASC-2 Parent Form, had an overall 
mean of 51.85 (SD = 7.21) for children treated with monotherapy and 61.00 (SD = 7.08) 
for children treated with polytherapy. These scores indicated a statistically significant 
difference between parent report of anxiety and treatment with AEDs, with polytherapy 
indicating increased anxiety symptoms, F(1, 49) = 18.45, p < .001. The effect size for the 
difference in mean scores between children with monotherapy versus polytherapy was 
small for parent report (d = 0.27).The skewness and kurtosis values indicated a fairly 
normal distribution of scores for children with monotherapy and polytherapy (skewness = 
0.80, -0.16; kurtosis = 0.05, -0.85, respectively). See Table 3 for additional data. 
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Defining Characteristics of BASC-2 Depression Scale: Child Self-Report 
Depression and Seizure Type 
 Depressive symptoms, as measured by the BASC-2 Child Form, had an overall 
mean of 56.24 (SD = 9.71) for children with generalized seizures and 53.63 (SD = 8.74) 
for children with partial seizures. These scores did not indicate a statistically significant 
difference in depressive symptoms for children with generalized seizures and partial 
seizures, F(1, 49) = 1.00, p = .322. The effect size for the difference in mean scores 
between children with generalized and partial seizures was small for self-report (d = 
0.02). The skewness and kurtosis values indicated a fairly normal distribution of scores 
for children with generalized and partial seizures (skewness = 0.06, 0.35; kurtosis = -0.92, 
-0.59, respectively). 
Depression and Seizure Frequency 
 Depressive symptoms, as measured by the BASC-2 Child Form, had an overall 
mean of 50.43 (SD = 7.71) for children with seizures 0 to 5 times in the last 12 months 
and 59.91 (SD = 8.10) for children with 6 to 12 seizures within the previous year. These 
scores indicated a statistically significant difference between self-report of depressive 
symptoms and frequency of seizures, with children with more seizures (5-12 within the 
last year) indicating increased depressive symptoms, F(1, 49) = 18.27, p < .001. The 
effect size for the difference in mean scores between children with more and less seizures 
was small for self-report (d = 0.27). The skewness and kurtosis values indicated a fairly 
normal distribution of scores for children with less frequent seizures (i.e., zero to five 
seizures in last year) and children with more frequent seizures (i.e., 6 to 12 seizures in 
last year) (skewness = 0.60, -0.09; kurtosis = -0.12, -0.77, respectively). 
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Depression and Use of AEDs 
  Depressive symptoms, as measured by the BASC-2 Child Form, had an overall 
mean of 50.82 (SD = 7.49) for children treated with monotherapy and 62.47 (SD = 7.05) 
for children treated with polytherapy. These scores indicated a statistically significant 
difference between self-report of depressive symptomatology and treatment with AEDs, 
with polytherapy indicating increased depressive symptoms, F(1, 49) = 28.48, p < .001. 
The effect size for the difference in mean scores between children with monotherapy 
versus polytherapy was medium for self-report (d = 0.37). The skewness and kurtosis 
values indicated a fairly normal distribution of scores for children with monotherapy and 
polytherapy (skewness = 0.49, -0.08; kurtosis = -0.37, -0.90, respectively).  
Defining Characteristics of BASC-2 Depression Scale: Parent Report 
Depression and Seizure Type 
 Depressive symptoms, as measured by the BASC-2 Parent Form, had an overall 
mean of 58.14 (SD = 9.26) for children with generalized seizures and 56.97 (SD = 5.35) 
for children with partial seizures. These scores did not indicate a statistically significant 
difference between parent-report of depressive symptomatology and type of seizure, with 
parents’ indicating increased depressive symptoms for children with generalized seizures, 
F(1, 49) = 0.33, p < .569. The effect size for the difference in mean scores between 
children with generalized and partial seizures was small for parent report (d = 0.01). The 
skewness and kurtosis values indicated a fairly normal distribution of scores for children 
with generalized and partial seizures (skewness = 0.06, 0.75; kurtosis = -0.68, 1.91, 
respectively). 
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Depression and Seizure Frequency 
 Depressive symptoms, as measured by the BASC-2 Parent Form, had an overall 
mean of 54.89 (SD = 4.78) for children with seizures 0-5 times in the last 12 months and 
60.57 (SD = 8.36) for children with 6 to 12 seizures within the previous year. These 
scores indicated a statistically significant difference between parent report of depressive 
symptomatology and frequency of seizures, with children with more seizures (5-12 
within the last year) having increased depressive symptoms, F(1, 49) = 9.24, p < .004. 
The effect size for the difference in mean scores between children with more and less 
seizures was small for parent report (d = 0.16). The skewness and kurtosis values 
indicated a fairly normal distribution of scores for children with less frequent seizures 
(i.e., zero to five seizures in last year) and children with more frequent seizures (i.e., 6 to 
12 seizures in last year) (skewness = -0.39, -0.21; kurtosis = -0.59, 0.01, respectively).  
Depression and Use of AEDs 
 Depressive symptoms, as measured by the BASC-2 Parent Form, had an overall 
mean of 56.03 (SD = 6.27) for children treated with monotherapy and 60.29 (SD = 8.13) 
for children treated with polytherapy. These scores indicate a statistically significant 
difference between parent report of depressive symptoms and treatment with AEDs, with 
polytherapy indicating increased depressive symptomatology, F(1, 49) = 4.29, p < .044. 
The effect size for the difference in mean scores between children treated with 
monotherapy versus polytherapy was small for parent report (d = 0.08). The skewness 
and kurtosis values indicated a fairly normal distribution of scores for children with 
monotherapy and polytherapy (skewness = 0.58, -0.25; kurtosis = 0.59, 1.04, 
respectively). See Table 3 below for additional data. 
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Table 3 
 
Skewness and Kurtosis Coefficients for BASC-2 (n = 51) 
 
 Child Self-Report Parent Report 
 Anxiety Scale 
Depression 
Scale 
Anxiety 
Scale 
Depression 
Scale 
Skewness -0.33 0.24 0.38 0.36 
Std. Error of 
Skewness 0.33 0.33 0.33 0.33 
Kurtosis -0.66 -0.81 -0.87 0.35 
Std. Error of 
Kurtosis 0.66 0.66 0.66 0.66 
 
 
 
Understanding Aspects of Health-Related Quality of Life in the Current Study 
Of the 51 child-parent participant pairs, scores derived from the Child Self-Report 
Form of the BASC-2 Anxiety Scale indicated that 68.6% (n = 35) of the child 
participants fell in the normal range for anxiety (i.e., T < 60), 29.4% (n = 15) of the child 
participants fell in the borderline range for anxiety (i.e., T = 60-69) and 2.0% (n = 1) fell 
in the clinically significant range (i.e., T = 70 or higher). On the BASC-2 Depression 
Scale, 68.6% (n = 35) of child participants had scores in the normal range of functioning, 
23.6% (n = 12) of child participants had scores in the borderline range (at-risk) for 
depression, and 7.8% (n = 4) of child participants had self-reported scores in the 
clinically significant range for depression.  
Based on parent report, the BASC-2 Parent Forms revealed that 68.6% (n = 35) of 
children obtained scores in the normal range for anxiety, 25.5% (n = 13) of children 
obtained scores in the borderline range, and 5.9% (n = 3) of children obtained scores in 
 86
the clinically significant range for anxiety. Regarding depressive symptomatology, 
parents’ ratings indicated that 70.6% (n = 36) of children were in the normal range of 
functioning, while 23.5% (n = 12) of children were functioning in the at-risk range for 
depression, and 5.9% (n = 3) of children were functioning in the clinically significant 
range for depression. This researcher hoped to discover which seizure-related variables 
and internalizing symptoms were most predictive of health-related quality of life. The 
following section will address the research questions for this study as presented in 
Chapter 1.  
Research Findings 
 Question 1. What seizure-related variables (i.e., type of seizure, seizure 
frequency, and treatment with AEDs) and psychopathology (“at-risk” or “clinically 
significant” range for anxiety and/or depression) best predict health-related quality of life 
as reported by children 8 to 11 years of age diagnosed with epilepsy?  
To address this research question, a canonical correlation analysis was computed. 
However, prior to conducting this analysis, the researcher wanted to ascertain the 
relationship between each independent and dependent variable in the study. Bivariate 
correlations (i.e., Pearson’s correlations) for all of the variables in the analysis are 
presented in Table 4. Because 45 correlations were of interest in Table 4, the Bonferroni 
adjustment had to be applied to ensure that the experiment-wise error rate did not exceed 
its nominal value of 5%. Thus, the adjusted Bonferroni α level of .0011 (i.e., .05/45) was 
used. According to the Pearson’s product moment correlation analysis, scores indicated a 
moderately strong, positive relationship between ratings of seizure frequency and 
children’s self-report of anxiety (r = .41) and depression (r = .52). All five subscales on 
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the HRQL measure had negative and moderately strong relationships with seizure 
frequency (see Table 4). Treatment with AEDs had a moderate, positive relationship with 
children’s ratings of anxiety (r = .46) and a strong, positive relationship with children’s 
ratings of depression (r = .61). Furthermore, strong, negative relationships were found 
among all five HRQL subscales and treatment with AEDs. Children’s ratings of anxiety 
were moderately correlated with all five subscales of the HRQL measure, with ratings of 
depression being very strongly correlated with the five HRQL subscales (see Table 4 for 
list of all correlation coefficients). It is noteworthy that all five subscales from the HRQL 
measure were strongly correlated with one and another, with correlation coefficients 
ranging from r = .72 to .83. Given that a correlational relationship was found between 
ratings of anxiety and depression, it seemed reasonable to proceed with canonical 
correlation analyses to determine whether a statistically significant relationship existed 
between the two certain sets of variables. 
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Table 4 
Pearson’s Correlations (Child Self-Report) 
 Seiz 
Type 
Seiz 
Freq 
AED Anx 
CH 
Dep 
CH 
Social 
CH 
Pres 
CH 
Emot 
CH 
Secr 
CH 
Norm 
CH 
Seiz 
Type 
1          
Seiz 
Freq 
-.36* 1         
AED 
-.42* .53* 1        
Anx 
CH 
-.11 .41* .46* 1       
Dep 
CH 
-.14 .52* .61* .66* 1      
Social 
CH 
.20 -.58* -.69* -.58* -.78* 1     
Present 
CH  
.12 -.53* -.59* -.63* -.77* .83* 1    
Emot 
CH 
.18 -.42* -.59* -.63* -.74* .76* .80* 1   
Secr 
CH 
.12 -.46* -.44* -.51* -.76* .72* .68* .82* 1  
Norm 
CH 
.07 -.58* -.52* -.67* -.79* .83* .82* .83* .79* 1 
* Statistically significant at the Bonferroni-adjusted level of .0011 (i.e., .05/45). 
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Statistical Assumptions for Canonical Correlation Analysis  
The statistical assumptions presented and discussed in Chapter 3 were assessed 
(when feasible) to determine if the specific assumptions pertaining to canonical 
correlation analysis were met. Univariate normality (i.e., skewness and kurtosis) was 
obtained for all variables examined in this study. However, one cannot assume that 
multivariate normality (i.e., multivariate skewness and kurtosis) also was obtained. 
Canonical Correlation Analysis (Child Report) 
 
 Using canonical correlation analysis, a composite of the quality of life subscales 
that correlate with a composite of seizure-related variable, anxiety, and depression was 
derived. Two independent canonical correlation analyses were computed; one utilized 
data derived via self-report, and the other utilized data obtained via parent-report. The 
first analysis consisted of five independent variables (i.e., seizure type, seizure frequency, 
AED treatment, anxious symptoms [via self-report], and depressive symptoms [via self-
report]) and five HRQL dependent variables—all of which were derived from child self-
report (i.e., social, present, emotion, secrecy, and normalcy). Table 5 presents 
information about the first canonical function (the only function that was statistically 
significant). This first function had a canonical correlation coefficient of .94, which 
indicates that the most variance is attributed to this first pair of linear combinations 
(statistically significant at p < .001). The second function, which had a canonical 
correlation coefficient of .55, had far less variance associated with it and therefore was 
not statistically significant using Bartlett’s approximate chi-square test (Χ2 = 14.51, df = 
16, p = .561).  
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 The standardized function coefficients for the first canonical function also are 
presented in Table 5. These standardized coefficients indicate the relative contribution of 
each independent variable to the variance of its respective within-set canonical variable. 
An examination of the standardized function coefficients revealed that of the five 
independent variables (i.e., seizure type, seizure frequency, AED treatment, anxious 
symptoms, and depressive symptoms), only depression (as rated by child participants) 
made a significant contribution to the dependent variables composite (i.e., social, present, 
emotion, secrecy, and normalcy).  
 Additionally, the structure coefficients are presented in Table 5 to provide more 
information about the relationships across pairs of canonical variates. Structure 
coefficients are the correlations between a given variable and the scores on the canonical 
composite (i.e., latent variable) in the set to which the variable belongs. Thus, structure 
coefficients indicate the degree of relationship of a given variable in the set with the 
canonical composite for the variable set (Thompson, 1984). Structure coefficients greater 
than +0.30 were considered to be practically significant (Hair, Anderson, Tatham, & 
Black, 1998). The structure coefficients revealed that four of the five independent 
variables (i.e., seizure frequency, AED treatment, anxious symptoms, and depressive 
symptoms) made important contributions to the first canonical variate. The size of the 
structure coefficient indicated that all four of these independent variables made very large 
contributions, with depression making the largest contribution. With regard to the 
dependent set, all five variables made large contributions, social making the largest 
contribution, followed closely by present. 
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Finally, the cross loadings for the first canonical function are presented in Table 
5. The cross loadings are the most stable coefficients for reliable interpretation because 
they are the product of each variable’s canonical loading and the canonical correlation 
coefficient. Therefore, the cross loadings allow the most accurate/confident interpretation 
of relationships between independent and dependent variables in each canonical function 
(Hair et al., 1998). Data generated from the cross loadings indicate that depression 
contributes the most to the relationship with the dependent variable composite. 
Additionally, seizure frequency, AED treatment, and anxiety, respectively, make 
significant contributions on the first canonical function for the set of dependent variables. 
With respect to the dependent variables set, all five variables made an important 
contribution to the composite set, with social and present making the most significant 
contribution, followed closely by normalcy, secrecy, and emotion, respectively.  
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Table 5 
Canonical Correlations (Child Self-Report) for First Canonical Function 
Variable Can r 
Wilks 
 Χ
2 Df P Std. Coeff 
 
Struct 
Coeff 
 
Cross 
Ldgs 
1 .937 .077 80.84 25 .0001    
Independent 
Variables: 
 
        
Seize Type      .11 -.25 -.24 
Seize Freq      .24 .84 .79 
AED      .16 .76 .72 
Anx CH      .02 .75 .71 
Dep CH      .70 .98 .92 
Dependent 
Variables: 
 
        
Soc CH      -.42 -.97 -.91 
Pres CH      -.36 -.95 -.89 
Emot CH       .01 -.85 -.80 
Secr CH      -.16 -.88 -.83 
Norm CH      -.13 -.92 -.86 
 
Can r = canonical r 
Std. Coeff = standardized function coefficient 
Struct Coeff = structure coefficient  
Cross Ldgs = cross-loadings 
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 Question 2. What seizure-related variables (i.e., type of seizure, seizure 
frequency, and treatment with AEDs) and psychopathology (“at-risk” or “clinically 
significant” range for anxiety and/or depression) best predict health-related quality of life 
as reported by parents of children 8 to 11 years of age diagnosed with epilepsy?   
This research question was addressed by computing a second canonical 
correlation analysis with data obtained via parent report. Prior to conducting this analysis, 
bivariate correlations (i.e., Pearson’s correlations) were computed for all of the variables 
in the analysis. These results are presented in Table 6. As previously indicated, because 
45 correlations were of interest in Table 4, the Bonferroni adjustment had to be applied to 
ensure that the experiment-wise error rate did not exceed its nominal value of 5%. Thus, 
the adjusted Bonferroni α level of .0011 (i.e., .05/45) was used. According to the 
Pearson’s product moment correlation analysis, scores indicated a moderately strong, 
negative relationship between ratings of seizure type and parent report of anxiety (r 
=.32). Seizure frequency had a moderately strong, positive relationship with anxiety (r = 
.51) and depression (r = .40). Additionally, treatment with AEDs had a moderately 
strong, positive relationship with anxiety (r = .52) and a small correlation with depression 
(r = .28; significant at the .05 alpha level). Parents’ ratings of anxiety were highly 
correlated with all five subscales of the HRQL measure, with correlations ranging from -
0.74 to -0.78. Parent ratings of depression also were highly correlated with the five 
subscales of the HRQL measure, ranging from -0.58 for social concerns to -0.74 for 
secrecy issues. 
Seizure type had a small, positive correlation with four of the five subscales on 
the HRQL measure (i.e., social, future, emotion, and secrecy). Seizure frequency had 
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moderately strong, negative correlations with all five subscales on the HRQL measure.  
Finally, treatment with AEDs had strong, negative correlations with all five HRQL 
subscales (see Table 6). It is noteworthy that all five subscales from the HRQL measure 
were strongly correlated with one and another, with correlation coefficients ranging from 
r = .83 to .93. Given that a correlational relationship was found among ratings of seizure-
related variables, psychopathology, and HRQL, it seemed reasonable to proceed with 
canonical correlation analyses to determine whether a statistically significant relationship 
existed among certain sets of variables.  
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Table 6 
Pearson’s Correlations (Parent-Report) 
 Seiz 
Type 
Seiz 
Freq 
AED Anx 
PR 
Dep 
PR 
Social 
PR 
Pres 
PR 
Fut 
PR 
Emot 
PR 
Secr 
PR 
Seiz 
Type 
1          
Seiz 
Freq 
-.36* 1         
AED 
-.42* .53* 1        
Anx  
PR 
-.32* .53* .52* 1       
Dep  
PR 
-.08 .40* .28* .51* 1      
Social 
PR 
.30* -.53* -.39* -.78* -.58* 1     
Pres  
PR 
.26* -.60* -.46* -.76* -.73* .87* 1    
Fut  
PR 
.33* -.60* -.53* -.78* -.67* .90* .93* 1   
Emot 
PR 
.31* -.53* -.39* -.77* -.69* .83* .90* .88* 1  
Secr 
PR 
.32* -.52* -.42* -.74* -.74* .87* .91* .91* .92* 1 
 
* Statistically significant at the Bonferroni-adjusted level of .0011 (i.e., .05/45). 
 96
Canonical Correlation Analysis (Parent Report) 
 
 Using canonical correlation analysis, a composite of the quality of life subscales 
that correlate with a composite of seizure-related variables, anxiety, and depression was 
derived. The second (parent) analysis consisted of five independent variables (i.e., seizure 
type, seizure frequency, AED treatment, anxious symptoms [via parent report], 
depressive symptoms [via parent report]) and five HRQL dependent variables; all of 
which were derived from parent report (i.e., social, present, future, emotion, and secrecy). 
Table 7 presents information about the first canonical function (the only function that was 
statistically significant). This first function had a canonical correlation coefficient of .927, 
which indicated that the most variance was attributed to this first pair of linear 
combinations (statistically significant at p < .001). The second function had a correlation 
coefficient of .533 had far less variance associated with it and therefore was not 
statistically significant using Bartlett’s approximate chi-square test (Χ2 = 20.26, df = 16,  
p = .209). 
 The standardized function coefficients also are presented in Table 7. The 
standardized coefficients indicate the relative contribution of each independent variable 
to the variance of its respective within-set canonical variable. The data suggest that 
depression (r = .43) as rated by parent participants contributes the most to the relationship 
with the first canonical variable, followed by seizure frequency (r = .36) and anxiety (r = 
.31). With respect to the dependent variables set, present and emotion made moderate 
contributions to the composite set.  
 Additionally, the structure coefficients are presented in Table 7 to provide more 
information about the relationships across pairs of canonical variates. Structure 
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coefficients are the correlations between a given variable and the scores on the canonical 
composite (i.e., latent variable) in the set to which the variable belongs. Thus, structure 
coefficients indicate the degree of relationship of a given variable in the set with the 
canonical composite for the variable set (Thompson, 1984). Structure coefficients greater 
than +0.30 were considered to be practically significant (Hair et al., 1998). An 
examination of the structure coefficients revealed that all five independent variables 
made significant contributions to the dependent variables composite–with seizure 
frequency and anxiety making the largest contributions. The structure coefficients 
revealed that all five independent variables made significant contributions to the first 
canonical variate—with seizure frequency and anxious symptoms making the largest 
contributions, and seizure type making the smallest contribution. With regard to the 
dependent set, all five variables made very large contributions, with present making the 
largest contribution, followed closely by emotion, future, secrecy, and social, 
respectively. 
Finally, the cross loadings are presented in Table 7. An examination of the cross 
loadings revealed that seizure frequency (r = .79), anxiety (r = .78), and depression (r = 
.74) made large contributions to the dependent variables composite, with AED treatment 
making a moderate contribution to the composite (r = .60). The fifth independent 
variable, seizure type, made the smallest (although still statistically significant) 
contribution to the composite (r = -.44). With respect to the dependent variables set, all 
five variables made significant contributions to the composite set, with present concerns 
making the largest contribution, followed closely by future, emotion, secrecy, and social, 
respectively.  
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Summary of Canonical Correlation Analyses 
 Results of the canonical correlation analysis examining data derived via child 
report revealed that four out of five independent variables assessed (i.e., seizure 
frequency, AED treatment, anxiety, and depression) were significantly correlated with 
the five HRQL subscales. Specifically, depressive symptomatology provided the largest 
contribution on the first canonical function for the set of dependent variables. Data 
derived via parent report indicated that all five independent variables made significant 
contributions to the dependent variables composite, with seizure frequency, anxiety, and 
depression making the largest contributions, followed by a moderate contribution of the 
independent variable, AED treatment, and a relatively smaller contribution of the 
independent variable, seizure type. The implications of these findings are presented and 
discussed in the following chapter. 
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Table 7 
Canonical Correlations (Parent-Report) for First Canonical Function 
Variable Can r 
Wilks 
 Χ
2 Df P Std. Coeff 
 
Struct 
Coeff 
 
Cr Ld 
1 .927 .074 81.90 25 .0001    
Independent 
Variables: 
 
        
Seize Type      -.10 -.47 -.44 
Seize Freq      .36 .85 .79 
AED      .07 .65 .60 
Anx PR      .31 .84 .78 
Dep PR      .43 .80 .74 
Dependent 
Variables: 
 
        
Soc PR       .04 -.87 -.81 
Pres PR      -.35 -.98 -.91 
Future PR      -.26 -.96 -.89 
Emot PR      -.33 -.96 -.89 
Secrecy PR      -.13 -.96 -.89 
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Chapter 5 
Discussion 
Summary of Study 
 The present study was conducted to explore which seizure-related variables 
and/or psychopathology variables were most significantly correlated with health-related 
quality of life (HRQL) in children with epilepsy. This study was novel in nature because 
it was one of only several studies to explore the relationship of anxiety and depression on 
HRQL in children with epilepsy. Findings suggested that anxiety and depression were 
statistically significantly correlated with HRQL for both self-report and parent report 
measures. Moreover, several seizure-related variables were found to correlate with the 
social and present concerns subscales on HRQL. That is, on self-report measures, both 
seizure frequency and number of antiepileptic drugs (AEDs) were correlated with HRQL. 
For parent report measures, seizure type, frequency, and number of AEDs were 
correlated with HRQL. However, it is important to note that although statistical 
significance was found, it is questionable whether these findings were clinically 
significant. That is, the majority of scores generated from child- and parent-ratings fell in 
the sub-clinical range of functioning for anxiety and depression as measured on the 
BASC-2. This chapter summarizes the results from Chapter 4, discusses implications of 
the results, examines limitations, and suggests directions for future research.  
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Relationship between Seizure-Related Variables and Health-Related Quality of Life 
Seizure Frequency and Health-Related Quality of Life 
Seizure frequency, as rated by both child- and parent-report, was found to be 
correlated with all five subscales on the HRQL measure. These findings indicate that 
children who have more frequent seizures (between 6 and 12 per year) are more likely to 
experience a lowered HRQL, especially associated with present concerns (i.e., current 
worries) and social concerns. The social subscale of the HRQL assesses interpersonal 
issues such as children’s interactions with peers, their perceptions of friendships, and 
experiences of bullying behavior.  
The reduced HRQL scores could be related, in part, to the social stigma of 
epilepsy that has been well documented in the literature (Baker, 2001). The social stigma 
associated with epilepsy and seizures may stem from the unpredictability of behavior 
evident in individuals who experience seizures. Although the effect of race on health-
related quality of life (HRQL) was not a focus of the current research, a significant 
percentage of minority children and parents participated in this study, and the potential 
impact of race on HRQL should not be overlooked. In fact, Nei Wu et al. (2008) found 
that ethnic minority groups may face a double stigma (i.e., minority status and 
neurological condition) or a triple stigma (with the addition of mental health concerns). 
Minority groups may be more impacted by social concerns and/or negative social 
interactions; therefore, these groups may be less likely to seek mental health services. 
Given that epilepsy has historically been stigmatized, it is not surprising that adding 
psychopathology/mental health difficulties exacerbate the perceived stigma for 
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individuals who experience seizures. This may be an important variable to examine in 
future research studies that assess HRQL in the pediatric epilepsy population.  
Health-related locus of control (HLC) is defined as the degree to which 
individuals’ believe that their health is controlled by internal or external factors (Lau, 
1982). In other words, HLC measures the degree to which an individual believes that 
his/her health is or is not determined by his/her own behavior. HLC may play a 
significant factor in children’s present concerns regarding their epilepsy condition. For 
example, an individual with epilepsy typically has a poor sense of an internal locus of 
control and a strong awareness of an external locus of control (Asadi-Pooya, Schilling, & 
Glosser et al., 2007). This is especially true for individuals with epilepsy because of the 
unpredictability of when their seizures will occur. This unpredictability may lead 
individuals with epilepsy to experience an increase in feelings of helplessness and 
hopelessness, both with their cognitive and behavioral functioning.  
Given the lack of control over their seizure occurrence and the subsequent 
externally-based locus of control, children with epilepsy would benefit from increasing 
their self-efficacy as well as self-reliance in an attempt to decrease their dependence on 
others (e.g., parents, clinicians) as experts. One method to increase the self-efficacy of 
children with epilepsy would be to educate children about their condition. Children 
should be knowledgeable about their medical condition, including the symptoms, 
treatment options, and likely prognosis related to their seizure disorder. Education should 
be used as a first line of defense to increase children’s understanding of their condition. 
Additionally, as is developmentally-appropriate, children should play an active role in 
 103
their medical care because their involvement will likely lead to increased feelings of 
empowerment.  
Treatment with AEDs and Health-Related Quality of Life 
 Results from the current study also supported previous findings that number of 
AEDs and HRQL are correlated (Cushner-Weinstein et al., 2008; Herranz, Armijo, & 
Artega, 1988). To analyze the relationship between child depression and anti-epileptic 
drug treatment, Cushner-Weinstein and colleagues found a significant correlation 
between rates of depression (specifically, interpersonal problems) and polytherapy. 
Furthermore, these researchers found that children on polytherapy had scores indicating 
significant difficulties with interpersonal relationships, feelings of ineffectiveness, and 
negative self-esteem compared to scores of children on monotherapy. The current 
findings substantiate the relationship between number of AEDs and HRQL, indicating 
that increased numbers of AEDs are correlated with poorer quality of life. These findings 
highlight the importance of prescribing the least number of AEDs possible that 
successfully control seizure activity.  
Seizure Type and Health-Related Quality of Life 
 Type of seizure was found to be correlated with HRQL based on the parent 
ratings of children with seizure disorders, whereas children’s self-report on the HRQL 
subscales did not reveal a significant relationship with seizure type. It is important to 
note, however, that the correlation between parent ratings of HRQL and seizure type was 
small. Differing perceptions of parents and children is the most likely explanation for this 
finding. That is, the perceptions, concerns, and worries of parents are likely quite 
disparate from those of children (Eiser & Morse, 2001). Previous research has revealed 
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mixed findings regarding the effect of seizure type on the quality of life of individuals 
with epilepsy, with some researchers finding a significant correlation between type of 
seizure and HRQL (e.g., Baker, Gagnon, & McNulty, 1998) and other researchers failing 
to find a significant relationship (e.g., Jacoby, Baker, Steen, Potts, & Chadwick, 1996). 
Given the inconsistent findings regarding the relationship between these two variables, 
future researchers should attempt to ascertain the effect of seizure type on the health-
related quality of life of children with epilepsy. 
Relationship between Psychopathology, Seizure-related Variables, and HRQL 
Findings from the current study indicate that a statistically significant relationship 
exists among anxious symptomatology, seizure frequency, and HRQL (both parent and 
self-reported). It has been presumed that individuals’ level of anxiety would be directly 
related to the number of seizures they experience, with a positive correlation between 
seizure frequency and anxiety. Therefore, it was expected that individuals with more 
frequent seizures would report increased anxious symptomatology, and those with both 
frequent seizures and increased anxiety would, in turn, be correlated with a lowered 
health-related quality of life. However, researchers are now hypothesizing that it may not 
be the actual number of seizures that predicts level of anxiety; instead, it may be the 
individual’s perceived level of control that is correlated with anxiety (Pedroso de Souza 
& Salgado, 2006). That is, researchers have found that it is the perception with which 
individuals regard their seizure disorder that dictates their quality of life; this perception 
has a larger impact on HRQL than seizure-related variables such as type of seizure, 
seizure frequency, age of onset, and disease duration (Meador, 1993). 
 105
 Depression, as rated by self- and parent-report, was found to be significantly 
correlated with lowered HRQL in the current study. This result was not surprising given 
the previous research that revealed increased rates of depression in the adult literature 
(Robertson & Trimble, 1983). It is important for clinicians to recognize that children may 
manifest symptoms of depression differently than adults. For example, children tend to 
present with disruptive behaviors and/or irritability (Carlson & Cantwell, 1980; Ettinger 
et al., 1998). These symptoms may not be readily identified as symptoms of depression, 
making the identification of depression in children rather challenging. This reality 
highlights the need for practitioners to inquire directly about and assess specific 
depressive symptomatology.  
 Previous studies have found large percentages of adult patients with both 
unrecognized and untreated psychopathology; namely depression (Boylan et al., 2004; 
O’Donoghue et al., 1999). The few studies examining rates of depression in children with 
epilepsy reveal similar results (Ettinger et al., 1998). Given that the current study, along 
with previous studies, indicate that depression has a significant negative effect on health-
related quality of life in individuals with epilepsy, it is important to consider patients’ 
psychosocial functioning in addition to the standard seizure-related variables in order to 
provide comprehensive care to this population.     
Limitations of the Study 
Internal and External Validity 
 It is important to establish internal and external validity in a well-designed and 
effectively implemented study. However, the results of the current study have several 
possible threats to both internal and external validity. One possible threat to internal 
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validity of the findings is instrumentation (Onwuegbuzie, 2003); that is, because the 
instruments for this study are designed to obtain information from participants via self-
report, the researcher will not be able to ascertain with complete confidence the accuracy 
of the data collected. In addition, given that the data being requested are sensitive in 
nature (and have potential negative connotations), there is an increased likelihood that 
participants would minimize psychopathological symptomatology. Furthermore, there 
exists the possibility of a threat to construct-related validity (Onwuegbuzie, 2003) 
because items on the questionnaire and/or rating scales may be unclear or confusing to 
some participants. However, the score reliability of each scale and subscale on each 
measure has been previously validated.  
 Differential selection of participants, also known as selection bias, may be a threat 
to the internal validity of the findings. That is, there may be a notable distinction between 
participants who completed and returned the questionnaires and rating scales and those 
who did not complete and return these forms (Best & Kahn, 2003). In addition, there may 
be a threat to historical validity, such that external events may impact the participants’ 
responses (Best & Kahn, 2003).  
Several potential threats to external validity of the results of this study exist as 
well. One possible threat to external validity is population validity (Best & Kahn, 2003), 
whereby results are generalized to populations that are not included in the study, such as 
children with medical conditions other than epilepsy or children with co-morbid medical 
conditions. Another threat to external validity is ecological validity. This refers to the 
extent to which findings can be generalized across settings, conditions, and contexts 
(Onwuegbuzie, 2003). To control for the threat to ecological validity, the results of this 
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study will not be generalized to children diagnosed with epilepsy who do not also meet 
all inclusion criteria from this study. Temporal validity also may be a threat to external 
validity in this study. This refers to the extent that results from a study are applicable 
across time. Therefore, it is important to consider the function of time during the period 
of data collection for the study (Onwuegbuzie, 2003).  
Sample Size  
The sample size was minimally acceptable, and the principal investigator would 
have preferred to obtain a larger number of participants. However, the researcher had a 
rather small pool from which to draw the sample given the specific inclusion and 
exclusion criterion. Thus, with the small sample size, the ideal statistical procedures were 
not carried out because statistical significance may not have been ascertained. Given the 
smaller sample size obtained in this study, results should be interpreted with some 
caution as a larger sample size may have generated disparate results. 
It also is important to note the potential positive effects of medication on ratings 
of anxiety and depression. Research findings have revealed that anti-epileptic drugs 
(AEDs) used to manage seizures may have an effect on mood, with AEDs improving 
mood in children and adults with epilepsy (Messenheimer, 2002; Uvebrant & Bauzien. 
1994). Therefore, given that all participants in this research study used AEDs to manage 
seizures and AEDs may improve mood, these results may partially explain why the 
majority of self- and parent-reporters rated their levels of anxiety and depression in the 
sub-clinical range of functioning (i.e., 68.6% to 70.6% of the sample received scores in 
the normal range).  
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Contributions of the Study 
Although there is a dearth of research in the area of pediatric epilepsy and 
psychopathology, the research that has been conducted has documented a statistically 
significant relationship between epilepsy and psychopathology, specifically depression 
and anxiety (Caplan, Siddarth, & Gurbani, 2005). The current study contributes to the 
sparse literature in this area of pediatric research, by providing valuable information 
about the relationship among seizure-related variables, anxiety, depression, and health-
related quality of life in children diagnosed with epilepsy.  
It has been well established in the literature that health-related problems 
negatively impact children’s academic performance; therefore, the importance of 
addressing chronic health needs of children in schools is apparent (e.g., Power, Shapiro, 
& DuPaul, 2003). School psychologists are in the position to make large contributions to 
the health promotion of children in schools and ensure that both educational and health 
needs are appropriately addressed and successfully met. School psychologists should 
facilitate the coordination of educational, health, and mental health services for children 
with medical conditions (Power & Blom-Hoffman, 2004). Additionally, school 
psychologists should play a role in the provision of additional supports and services 
provided through IDEA and/or a Section 504 Accommodation Plan.  
Results from this study will hopefully highlight the importance of identifying, 
diagnosing, and treating children with epilepsy who have co-morbid psychopathology 
and poor health-related quality of life so that they may have the best possible educational 
and psychosocial outcomes. The Pediatric Psychosocial Preventative Health Model 
(PPPHM; Kazak, 2006) views pediatric health care through the view of a biopsychosocial 
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lens. That is, children and their families function in a multitude of complex systems, and 
when a child is affected with a chronic health condition the normal course of 
development is interrupted. The PPHM has three levels of prevention and intervention: 
universal, targeted, and clinical/treatment. The universal level represents the largest 
group of children and families entering the health care system in which children and 
families are distressed yet remain resilient. At the universal level it is assumed that the 
individuals are functioning normally and have adequate coping strategies; therefore, at 
this level general information and support is provided. A smaller number of children and 
families require support and services at the second (Targeted) level. At this level, 
children and families are experiencing acute distress and risk factors are identified; 
therefore, support and services tailored to the family’s specific needs are provided and 
distress is closely monitored. The third level (Clinical/Treatment) is reserved for children 
and families who are at-risk for persistent distress and for whom significant risk factors 
are identified. At this level, anxiety, depression, and other psychosocial difficulties may 
become apparent; therefore, these children and families receive the most intensive 
support and treatment.  
Given that other three-tiered models have been effectively introduced and 
implemented in the public school system (e.g., Response to Intervention), the PPPHM 
also could be successfully implemented in the school setting with psychologists and other 
mental health specialists playing important roles in the provision of services to students 
and their families. An effectual start may be to incorporate training for both psychologists 
and physicians regarding epilepsy and co-morbid psychopathology and its impact on 
HRQL. Physicians must work collaboratively with psychologists to address the medical 
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aspects and the psychosocial aspects of seizure disorders in children. Additionally, the 
importance of early, routine screenings to assess anxious and depressive symptomatology 
in children with seizure disorders should be emphasized. This effort could involve the 
combination of didactic training as well as supervisors and chief residents modeling best 
practices with the use of routine, early screenings for anxiety, depression, and health-
related quality of life for all children diagnosed with epilepsy. Additionally, it is 
imperative that information regarding the medical and psychosocial aspects of epilepsy is 
communicated to parents so that they are well-informed, empowered, and able to 
advocate most effectively for their children.  
While interventions historically have focused on the medical management of 
seizure disorders, findings from this study underscore the importance of treating anxiety 
and depression in children with epilepsy. Additionally, it is the hope of this researcher 
that children with epilepsy and their families will be informed of available preventative 
and early intervention services to address both the medical and psychosocial aspects of 
epilepsy. To provide a high quality level of care, practitioners need to incorporate 
prevention and intervention services that address children’s psychosocial functioning 
rather than focusing solely on the medical management of their seizures. These services 
may help enable children to lead a life with minimal psychosocial difficulties stemming 
from epilepsy and improve their overall quality of life.  
Future Research 
 Previous researchers have discovered that behavioral problems in children with 
epilepsy is a better predictor of parental depression than is the severity of the children’s 
seizure condition (Shore, Austin, Huster, & Dunn, 2001). In light of these findings, 
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important data would be gleaned by investigating rates of depression in the parents of 
children with epilepsy as well as parental coping skills. It would be advantageous for 
future researchers to glean information regarding the relationship between parental 
psychosocial functioning and the overall functioning of their children.  
Another important area that has not been explored by researchers is what 
strategies children with epilepsy use to define their personal and social reality and how to 
implement strategies that would increase their sense of personal control (Attarian, Vahle, 
& Carter, Hykes, & Gilliam 2003). That is, children with epilepsy would benefit from 
psychosocial interventions that would empower them and provide them with a stronger 
sense of support from their communities. Future studies must address the mechanisms 
that lead children to feel unsupported by their peers and community as well as what 
strategies could be implemented to build social support. Psychologists in education and 
medical settings are in the ideal position to provide both psycho-education and 
psychosocial support to children with epilepsy within the various systems in which they 
function.  
 Additionally, invaluable information could be gleaned regarding resilient factors 
that may protect children with epilepsy from psychopathology such as anxiety and 
depression. Future studies would benefit from examining resiliency in children and 
families inflicted with epilepsy to determine what factors help children become resilient. 
Moreover, information about resiliency in children with epilepsy could be incorporated in 
early intervention services to decrease the probability that children with epilepsy will 
develop co-morbid psychopathology and lowered health-related quality of life. 
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 It is hoped that this study has laid the groundwork for subsequent studies to 
explore further the role of psychopathology (especially anxiety and depression) on 
health-related quality of life in children with epilepsy. A future research path that would 
greatly augment the current research in this area would be to utilize a mixed methods 
research design, incorporating both quantitative and qualitative components. 
Furthermore, it may be beneficial to complete a qualitative research study prior to a 
quantitative study design with children diagnosed with seizure disorders. The above-
mentioned research components would enable researchers to understand better how 
children with epilepsy conceptualize internalizing disorders such as anxiety and 
depression. Although researchers have developed measures to assess HRQL for specific 
pediatric populations, children may conceptualize HRQL differently. Therefore, studies 
that include qualitative components such as focus groups may be better aligned with 
children’s own perceptions. Additionally, it is important that future researchers explore 
the relationship between parents’ and children’s ratings of psychopathology and HRQL. 
Adding a qualitative component, such as focus groups, would provide invaluable 
information about the similarities and differences between parent and child perceptions of 
epilepsy and its impact on psychosocial functioning and overall quality of life. 
 Furthermore, future researchers may want to investigate additional variables that 
were not examined in this study. For example, it may be advantageous to determine 
which factors contribute to increased perceived control in children with epilepsy. It is 
critical to examine outcome variables in addition to health-related quality of life because 
it is likely that seizure disorders (especially with co-morbid anxiety and depression) have 
a broad impact on children’s functioning. For example, it would be beneficial to 
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understand the relationship between psychopathology and academic performance in 
children with seizures. This study could be replicated with additional variables to assess 
the relationship among psychopathology, academic functioning, and HRQL. These data 
would allow for more comprehensive interventions to alleviate negative emotions, 
cognitions, and behaviors as well as address variables that impact the educational success 
of children with epilepsy.  
 Future researchers also may benefit from including a larger age range of 
participants, perhaps including adolescents to examine risk and resilience factors specific 
to an adolescent population. The inclusion of older children/adolescents also may provide 
greater insight regarding the effect of seizure-related variables and psychopathology on 
HRQL as younger children are likely less introspective and may have more difficulty 
identifying anxious and depressive symptomatology and the effect on their HRQL. 
Finally, another relationship that should be teased out is the correlation between the 
socio-economic status of families and the presence of psychopathology and/or lowered 
health-related quality of life in children with epilepsy. Determining the relationship 
between SES and children’s psychosocial functioning may provide valuable information 
for the development of interventions and support services for children with epilepsy. 
Final Thoughts 
 Psychopathology and poor health-related quality of life is a significant concern 
for children with epilepsy and their families. Given that children who manifest symptoms 
of anxiety and depression have significantly lowered HRQL, it is apparent that 
psychopathology has implications for the mental health of children with epilepsy. This 
study was one of only several to examine internalizing disorders and HRQL in children 
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with epilepsy. It was hypothesized that significant correlations would be found between 
specific seizure-related variables, anxiety, depression, and the outcome variable (HRQL). 
It is imperative that clinicians and researchers alike utilize existing research findings to 
develop prevention and intervention programs for children at greatest risk for poor 
HRQL.  
 The overall quality of life of children with epilepsy should be a primary focus of 
their treatment. It is hoped that findings generated from this study serve to be an impetus 
to developing interventions that will improve their quality of life. Given the importance 
of early identification and intervention for children with co-morbid epilepsy and 
psychopathology, it is critical that professionals who are in the position to identify these 
children obtain the knowledge and resources necessary to provide children with the 
supports and services needed as early as possible after seizure diagnosis. Practitioners 
working with children and families impacted by epilepsy have the privileged opportunity 
to identify and ameliorate the numerous challenges this population endures.   
Although research findings reveal that as many as 33% of children with epilepsy 
have co-morbid psychopathology (Caplan et al., 2005), it is also evident in the literature 
that the majority of children with psychopathology do not receive appropriate mental 
health services. If the relationship among seizure-related variables, internalizing 
disorders, and health-related quality of life is ascertained, then children with epilepsy 
who are at-risk for poorest HRQL may be identified early and receive mental health 
services as appropriate. It is quite clear that changes in treatment must occur so that 
children with epilepsy may receive adequate medical and psychological services. 
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Appendix A: Demographics and Seizure Variables Questionnaire 
 
Demographics and Seizure-Related Variables Questionnaire 
 
Please read the items below and circle or write-in one response for each item. If you have any questions 
about this form, please ask for assistance.  
 
(1)  My child’s age is: ________________ 
 
(2)  My child’s gender is:   Male  Female 
 
(3)  My child’s race/ethnic identity is: African American/Black Hispanic/Latino 
  
     Asian American   Native American 
 
     Caucasian/White  Mixed-Race or Other  
 
(4)  Type of medical insurance:  Private   Medicaid  None 
 
(5a)  Does your child have any medical/physical diagnoses in addition to epilepsy?  
        (for example: cystic fibrosis, diabetes, asthma) 
 
   Yes    No 
 
(5b)  If you answered yes to (5a), please provide the diagnosis: ________________________ 
 
(6a)  Does your child have any emotional/behavioral diagnoses? (for example: attention     
        deficit-hyperactivity disorder, autism, depression) 
 
   Yes    No 
 
(6b)  If you answered yes to (6a), please provide the diagnosis: ________________________ 
 
(7)  Please circle the type of seizure your child experiences: 
 
   Generalized seizures  Partial seizures 
  
(8)  Number of seizures in the past 12 months: 
 
   0-5 per year   6-12 per year 
 
(9)  Please list all medications your child has been taking for the past 3 months:  
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
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Appendix B: Child Cover Letter and Assent Form 
 
Hello! 
You and your parent are being asked to take part in a research study by filling out several 
surveys. I am trying to find out what types of things impact the quality of life of children with 
epilepsy. 
 
9 Why You Should Take Part in the Study:  I want to learn more about what things impact the 
lives of kids with epilepsy. Any information you give will be confidential: that means it is 
private. Also, you and your parent will be entered into a drawing to win a $100 gift card!  
 
9 Filling Out the Surveys:  These surveys will ask about your thoughts, behaviors, and attitudes 
about different things. I expect it will take you about 30 minutes to fill out the surveys.    
 
9 Confidentiality (Privacy) of Your Responses:  I do not expect that there will be more than 
minimal risk to you for taking part in this research study. The information you provide will be 
kept confidential (private, secret). Your surveys will have a code number to protect the 
privacy of your responses.  
 
9 Please Note:  Your involvement in this study is voluntary: you get to decide if you want to 
fill out the surveys. By signing this form, you are agreeing to take part in this research. If you 
choose not to participate, or if you want to stop participating at any time, you will not be 
punished in any way. You are free to stop participating in this study at any time.  
 
9 What We’ll Do With Your Responses:  I will use the information from this study to let others 
know what sort of things impact the lives of kids with epilepsy. The results of this study may 
be published; however, your responses will be combined with responses from other people. 
The published results will not include your name or any other information that would in any 
way identify you.  
 
9 Questions?  If you have any questions about this research study, you may contact me (Ms. 
Aja Meyer) at (813) 810-2526. If you have questions about your rights as a person who is 
taking part in a research study, you may contact a member of the Division of Research 
Compliance of the University of South Florida at 813-974-5638 or the Department of Health 
and Human Services. 
 
 
Thank you for taking the time to take part in this study. 
 
Sincerely, 
 
Aja Meyer, M.A.     
Doctoral Candidate   
Psychological and Social Foundations  
University of South Florida 
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Appendix B: (Continued) 
 
Assent to Take Part in this Research Study 
 
 
I freely give my permission to take part in this study. I understand that this is research. I have 
received a copy of this letter and assent form for my records. 
 
 
________________________  ________________________  ____________  
Signature of child   Printed name of child   Date  
taking part in the study 
 
 
 
 
Statement of Person Obtaining Informed Assent 
 
I certify that participants have been provided with an informed assent form that has been 
approved by the University of South Florida’s Institutional Review Board and that explains the 
nature, demands, risks, and benefits involved in participating in this study. I further certify that a 
phone number has been provided in the event of additional questions.  
 
 
________________________ ________________________ ___________ 
Signature of person Printed name of person  Date 
obtaining assent obtaining assent 
 
 
 
 
 
 
 
 
Investigator Statement:  
 
I certify that participants have been provided with an informed consent form that has been 
approved by the University of South Florida’s Institutional Review Board and that explains the 
nature, demands, risks, and benefits involved in participating in this study. I further certify that a 
phone number has been provided in the event of additional questions.  
 
 
_________________________             ________________________              _____________ 
Signature of Investigator  Printed Name of Investigator  Date 
 134
Appendix C: Parent Cover Letter and Consent Form 
 
Dear Parent or Guardian: 
 
This letter provides information about a research study that will be conducted at Dr. Fernandez’s office by 
Aja M. Meyer, M.A., a doctoral candidate from the University of South Florida. Please carefully read 
through this information and sign the bottom of the form.  
 
Purpose of study: The purpose of the study is to determine which factors are correlated with quality of life 
in children with epilepsy so they may receive appropriate supports and services to improve their physical 
and psychosocial well-being. This study is part of my dissertation research entitled, “Impact of Seizure-
Related Variables and Psychopathology on Health-Related Quality of Life in Pediatric Epilepsy.” 
Information from this study will inform educators and psychologists about the relationship between seizure 
variables and internalizing disorders (i.e., anxiety and depression) and the health-related quality of life of 
children with epilepsy.  
 
What participation requires: If you and your child agree to take part in this study, you both will be 
requested to complete several forms. You will be asked to complete a short questionnaire requesting basic 
information about your child’s medical condition, a rating scale that assesses your child’s behavioral and 
emotional symptoms, and a rating scale that measures your child’s health-related quality of life. These 
forms should take approximately 40 minutes to complete. Your child will be asked to complete the child 
version of the two rating scales. It should take your child about 30 minutes to complete these scales. Please 
note that all forms should be completed independently. However, if your child asks for help with some 
items from the forms, you may assist them, but you should not provide the responses for them. 
 
Risks and benefits: There are no direct risks or benefits to you or your child for participating in this study; 
however, by participating you will provide valuable information about the factors that impact the quality of 
life of children with epilepsy. If the researcher should find that your child is at-risk for depression or 
anxiety (based on scores obtained on the BASC-2 questionnaire), Dr. Fernandez will be informed that code 
number participant “XXX” is in the at-risk range for depression and/or anxiety. Dr. Fernandez will match 
the participant with the code number on the consent form and may refer the patient for further evaluation. 
Compensation: Each child/guardian pair who participates in this study will be included in a drawing to 
win a $100 gift card.  
 
Confidentiality: There are federal laws that say I must keep your study records private. Your records will 
be kept private by not asking for information that could identify you or your child. However, certain people 
may need to see your study records, and they must keep your records completely confidential. The only 
people who are allowed to view your records are the research team members, the University of South 
Florida Institutional Review Board staff, and government agencies who make sure that your rights and 
safety are being protected. I may publish what I learn from this study; however, nothing will be published 
that would let people know who you are.   
 
Voluntary Participation: You and your child’s participation in this study is completely voluntary. Your 
decision to take part in this study will not affect your current or future relationship with Dr. Fernandez. If at 
any time you have questions or concerns regarding this study, please contact the principal investigator (Aja 
M. Meyer) at 813-810-2526 or ameyer@mail.usf.edu. If you have questions or concerns about you or your 
child's rights as research subjects, you may contact the Institutional Review Board at the University of 
South Florida at 813-974-5638 or the Department of Health and Human Services. You may retain this letter 
for your personal records, if desired.  
 
Aja M. Meyer, M.A.      
Psychological and Social Foundations 
University of South Florida 
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Appendix C: (Continued) 
 
Consent for Child to Take Part in this Research Study 
 
 
 
I give consent for myself and my child to participate in this study. 
 
___________________  ______________________  __________ 
Signature of Participant  Printed Name of Participant  Date  
 
 
 
 
 
I do NOT give consent for myself and/or my child to participate in this study. 
 
___________________  ______________________  __________ 
Signature of Participant  Printed Name of Participant  Date  
 
 
 
 
 
 
 
Investigator Statement:  
 
I certify that participants have been provided with an informed consent form that has been 
approved by the University of South Florida’s Institutional Review Board and that explains the 
nature, demands, risks, and benefits involved in participating in this study.  I further certify that a 
phone number has been provided in the event of additional questions.  
 
_________________________  _________________________          _____________ 
Signature of Investigator  Printed Name of Investigator  Date 
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Appendix D: Health-Related Quality of Life: Parent Questionnaire 
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Appendix E: Health-Related Quality of Life: Child Questionnaire 
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Appendix E: (Continued) 
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